STOCK TITAN

[10-K/A] Northann Corp. Amends Annual Report

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
10-K/A
Rhea-AI Filing Summary

Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.” On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.

  • Nature of transaction: “A” code denotes acquisition from equity award; “F” code denotes shares withheld for taxes—neither represents an open-market trade.
  • Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
  • Alignment impact: The executive retains a sizable equity stake (≈3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.

Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.

Panoramica della dichiarazione Form 4: Clover Health Investments (CLOV) ha riportato un'attività interna da parte di Jamie L. Reynoso, indicata come “CEO, Medicare Advantage.” Il 30 giugno 2025 la Sig.ra Reynoso ha acquisito 217.523 azioni di Classe A tramite la tranche finale di un premio RSU basato sulle performance del 16 marzo 2023. Per soddisfare le imposte da trattenere, la società ha venduto automaticamente 85.596 azioni a 2,79 $ ciascuna. Dopo questa vendita automatica, la proprietà diretta della Sig.ra Reynoso ammonta a 3.328.328 azioni di Classe A, con un incremento di circa 132 mila azioni rispetto al saldo precedente.

  • Natura della transazione: Il codice “A” indica l’acquisizione tramite premio azionario; il codice “F” indica azioni trattenute per tasse—nessuno dei due rappresenta una compravendita sul mercato aperto.
  • Base di costo: Le RSU sono state liquidate senza costi in contanti per l’insider; solo la vendita per il pagamento delle tasse ha un prezzo di mercato.
  • Impatto sull’allineamento: L’esecutivo mantiene una partecipazione azionaria significativa (circa 3,3 milioni di azioni), rafforzando l’allineamento degli incentivi, ma non è stato effettuato alcun nuovo investimento in denaro.

In sintesi, la dichiarazione riflette una normale maturazione di compensi azionari e la relativa trattenuta fiscale, piuttosto che una decisione discrezionale di acquisto o vendita. L’impatto sul mercato è previsto neutrale salvo altri eventi.

Resumen de presentación del Formulario 4: Clover Health Investments (CLOV) reportó actividad interna por parte de Jamie L. Reynoso, listado como “CEO, Medicare Advantage.” El 30 de junio de 2025, la Sra. Reynoso obtuvo 217,523 acciones Clase A mediante el tramo final de una concesión de RSU basada en desempeño del 16 de marzo de 2023. Para cubrir las retenciones fiscales, la empresa vendió automáticamente 85,596 acciones a 2.79 $ por acción. Tras esta venta automática, la propiedad directa de la Sra. Reynoso es de 3,328,328 acciones Clase A, un aumento de aproximadamente 132 mil acciones respecto al saldo anterior.

  • Naturaleza de la transacción: El código “A” indica adquisición por premio de acciones; el código “F” indica acciones retenidas para impuestos—ninguno representa una operación en mercado abierto.
  • Base de costo: Las RSU se liquidaron sin costo en efectivo para el insider; solo la venta para impuestos tiene precio de mercado.
  • Impacto en alineación: El ejecutivo mantiene una participación accionaria significativa (aprox. 3.3 millones de acciones), reforzando la alineación de incentivos, pero no hubo nueva inversión en efectivo.

En general, la presentación refleja la consolidación rutinaria de compensación en acciones y la correspondiente retención fiscal, más que una decisión discrecional de compra o venta. Se espera un impacto neutral en el mercado salvo otros catalizadores.

Form 4 제출 개요: Clover Health Investments (CLOV)는 ‘Medicare Advantage CEO’로 등재된 Jamie L. Reynoso의 내부자 거래를 보고했습니다. 2025년 6월 30일, Reynoso 씨는 2023년 3월 16일 성과 기반 RSU 보상의 마지막 분할로 217,523주 클래스 A 주식을 취득했습니다. 원천징수 세금을 충당하기 위해 회사는 자동으로 85,596주를 주당 2.79달러에 매도했습니다. 자동 매도 후 Reynoso 씨의 직접 보유 주식은 3,328,328주 클래스 A로 이전 잔액 대비 약 13만 2천 주 증가했습니다.

  • 거래 성격: “A” 코드는 주식 수상에 따른 취득, “F” 코드는 세금 원천징수를 위한 주식 보유를 의미하며, 둘 다 공개 시장 거래는 아닙니다.
  • 원가 기준: RSU는 내부자에게 현금 비용 없이 정산되었으며, 세금 원천징수를 위한 매도만 시장 가격이 적용되었습니다.
  • 정렬 영향: 경영진은 상당한 지분(약 330만 주)을 유지하여 인센티브 정렬을 강화했으나, 신규 현금 투자는 없었습니다.

전반적으로 이번 제출은 임의의 매수 또는 매도 결정이 아닌, 정기적인 주식 보상 성숙 및 세금 원천징수를 반영합니다. 다른 촉매가 없으면 시장 영향은 중립적일 것으로 예상됩니다.

Présentation du formulaire 4 : Clover Health Investments (CLOV) a signalé une activité d’initié par Jamie L. Reynoso, désignée comme « CEO, Medicare Advantage ». Le 30 juin 2025, Mme Reynoso a acquis 217 523 actions de classe A lors de la dernière tranche d’une attribution de RSU basée sur la performance du 16 mars 2023. Pour couvrir les retenues fiscales, la société a automatiquement vendu 85 596 actions à 2,79 $ chacune. Après cette vente automatique, la détention directe de Mme Reynoso s’élève à 3 328 328 actions de classe A, soit environ 132 000 actions de plus que précédemment.

  • Nature de la transaction : Le code « A » indique une acquisition via attribution d’actions ; le code « F » des actions retenues pour impôts — aucune des deux n’est une transaction sur le marché libre.
  • Base de coût : Les RSU ont été réglées sans coût en espèces pour l’initié ; seule la vente liée à la retenue fiscale est au prix du marché.
  • Impact sur l’alignement : La dirigeante conserve une participation importante (environ 3,3 millions d’actions), renforçant l’alignement des incitations, mais aucun nouvel investissement en espèces n’a été effectué.

Globalement, le dépôt reflète un vesting habituel de compensation en actions et la retenue fiscale associée, plutôt qu’une décision discrétionnaire d’achat ou de vente. L’impact sur le marché est attendu neutre, sauf autres catalyseurs.

Übersicht zur Form 4 Einreichung: Clover Health Investments (CLOV) meldete Insider-Aktivitäten von Jamie L. Reynoso, aufgeführt als „CEO, Medicare Advantage.“ Am 30. Juni 2025 erhielt Frau Reynoso 217.523 Class A Aktien durch die letzte Tranche einer leistungsabhängigen RSU-Zuteilung vom 16. März 2023. Zur Begleichung der Quellensteuer verkaufte das Unternehmen automatisch 85.596 Aktien zu je 2,79 $. Nach dem automatischen Verkauf hält Frau Reynoso direkt 3.328.328 Class A Aktien, etwa 132.000 Aktien mehr als zuvor.

  • Art der Transaktion: Code „A“ steht für Erwerb durch Aktienzuteilung; Code „F“ für zurückbehaltene Aktien zur Steuerzahlung – beides keine offenen Markttransaktionen.
  • Kostenbasis: Die RSUs wurden ohne Barzahlung für den Insider abgewickelt; nur der steuerbedingte Verkauf erfolgte zum Marktpreis.
  • Auswirkung auf Ausrichtung: Die Führungskraft hält eine bedeutende Beteiligung (ca. 3,3 Millionen Aktien), was die Anreizausrichtung stärkt, jedoch wurde keine neue Barinvestition getätigt.

Insgesamt spiegelt die Einreichung eine routinemäßige Aktienvergütung und die damit verbundene Steuerabführung wider, keine diskretionäre Kauf- oder Verkaufsentscheidung. Die Marktauswirkung wird neutral erwartet, sofern keine weiteren Ereignisse eintreten.

Positive
  • Executive ownership rises by ~132,000 shares, increasing alignment with shareholders.
  • Performance-based vesting suggests the company met or exceeded predefined targets tied to the 2023 RSU grant.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting—neutral impact; insider’s stake increases, no open-market buying.

The 217.5 k share addition arises from a scheduled performance-based RSU vesting. The automatic 85.6 k-share sale merely covers payroll taxes. Net beneficial ownership growth of ~132 k shares (≈4 % of her prior holdings) is not large enough to signal a strong incremental vote of confidence, but it modestly enhances alignment. Because there is no discretionary purchase or sale, I view the filing as informational, not directional. Trading volume impact should be minimal.

TL;DR: Performance-based vesting confirms compensation plan progression; governance concerns minimal.

The disclosure shows Clover Health’s incentive structure functioning as designed: shares vest only after performance hurdles, with automatic tax withholding to avoid insider liquidity strain. The executive’s continued sizable ownership (3.3 M shares) exceeds common ownership guidelines, fostering shareholder alignment. There are no indications of problematic timing, 10b5-1 usage, or unusual dispositions. Therefore, the governance signal is neutral-to-slightly-positive, but not materially impactful to valuation.

Panoramica della dichiarazione Form 4: Clover Health Investments (CLOV) ha riportato un'attività interna da parte di Jamie L. Reynoso, indicata come “CEO, Medicare Advantage.” Il 30 giugno 2025 la Sig.ra Reynoso ha acquisito 217.523 azioni di Classe A tramite la tranche finale di un premio RSU basato sulle performance del 16 marzo 2023. Per soddisfare le imposte da trattenere, la società ha venduto automaticamente 85.596 azioni a 2,79 $ ciascuna. Dopo questa vendita automatica, la proprietà diretta della Sig.ra Reynoso ammonta a 3.328.328 azioni di Classe A, con un incremento di circa 132 mila azioni rispetto al saldo precedente.

  • Natura della transazione: Il codice “A” indica l’acquisizione tramite premio azionario; il codice “F” indica azioni trattenute per tasse—nessuno dei due rappresenta una compravendita sul mercato aperto.
  • Base di costo: Le RSU sono state liquidate senza costi in contanti per l’insider; solo la vendita per il pagamento delle tasse ha un prezzo di mercato.
  • Impatto sull’allineamento: L’esecutivo mantiene una partecipazione azionaria significativa (circa 3,3 milioni di azioni), rafforzando l’allineamento degli incentivi, ma non è stato effettuato alcun nuovo investimento in denaro.

In sintesi, la dichiarazione riflette una normale maturazione di compensi azionari e la relativa trattenuta fiscale, piuttosto che una decisione discrezionale di acquisto o vendita. L’impatto sul mercato è previsto neutrale salvo altri eventi.

Resumen de presentación del Formulario 4: Clover Health Investments (CLOV) reportó actividad interna por parte de Jamie L. Reynoso, listado como “CEO, Medicare Advantage.” El 30 de junio de 2025, la Sra. Reynoso obtuvo 217,523 acciones Clase A mediante el tramo final de una concesión de RSU basada en desempeño del 16 de marzo de 2023. Para cubrir las retenciones fiscales, la empresa vendió automáticamente 85,596 acciones a 2.79 $ por acción. Tras esta venta automática, la propiedad directa de la Sra. Reynoso es de 3,328,328 acciones Clase A, un aumento de aproximadamente 132 mil acciones respecto al saldo anterior.

  • Naturaleza de la transacción: El código “A” indica adquisición por premio de acciones; el código “F” indica acciones retenidas para impuestos—ninguno representa una operación en mercado abierto.
  • Base de costo: Las RSU se liquidaron sin costo en efectivo para el insider; solo la venta para impuestos tiene precio de mercado.
  • Impacto en alineación: El ejecutivo mantiene una participación accionaria significativa (aprox. 3.3 millones de acciones), reforzando la alineación de incentivos, pero no hubo nueva inversión en efectivo.

En general, la presentación refleja la consolidación rutinaria de compensación en acciones y la correspondiente retención fiscal, más que una decisión discrecional de compra o venta. Se espera un impacto neutral en el mercado salvo otros catalizadores.

Form 4 제출 개요: Clover Health Investments (CLOV)는 ‘Medicare Advantage CEO’로 등재된 Jamie L. Reynoso의 내부자 거래를 보고했습니다. 2025년 6월 30일, Reynoso 씨는 2023년 3월 16일 성과 기반 RSU 보상의 마지막 분할로 217,523주 클래스 A 주식을 취득했습니다. 원천징수 세금을 충당하기 위해 회사는 자동으로 85,596주를 주당 2.79달러에 매도했습니다. 자동 매도 후 Reynoso 씨의 직접 보유 주식은 3,328,328주 클래스 A로 이전 잔액 대비 약 13만 2천 주 증가했습니다.

  • 거래 성격: “A” 코드는 주식 수상에 따른 취득, “F” 코드는 세금 원천징수를 위한 주식 보유를 의미하며, 둘 다 공개 시장 거래는 아닙니다.
  • 원가 기준: RSU는 내부자에게 현금 비용 없이 정산되었으며, 세금 원천징수를 위한 매도만 시장 가격이 적용되었습니다.
  • 정렬 영향: 경영진은 상당한 지분(약 330만 주)을 유지하여 인센티브 정렬을 강화했으나, 신규 현금 투자는 없었습니다.

전반적으로 이번 제출은 임의의 매수 또는 매도 결정이 아닌, 정기적인 주식 보상 성숙 및 세금 원천징수를 반영합니다. 다른 촉매가 없으면 시장 영향은 중립적일 것으로 예상됩니다.

Présentation du formulaire 4 : Clover Health Investments (CLOV) a signalé une activité d’initié par Jamie L. Reynoso, désignée comme « CEO, Medicare Advantage ». Le 30 juin 2025, Mme Reynoso a acquis 217 523 actions de classe A lors de la dernière tranche d’une attribution de RSU basée sur la performance du 16 mars 2023. Pour couvrir les retenues fiscales, la société a automatiquement vendu 85 596 actions à 2,79 $ chacune. Après cette vente automatique, la détention directe de Mme Reynoso s’élève à 3 328 328 actions de classe A, soit environ 132 000 actions de plus que précédemment.

  • Nature de la transaction : Le code « A » indique une acquisition via attribution d’actions ; le code « F » des actions retenues pour impôts — aucune des deux n’est une transaction sur le marché libre.
  • Base de coût : Les RSU ont été réglées sans coût en espèces pour l’initié ; seule la vente liée à la retenue fiscale est au prix du marché.
  • Impact sur l’alignement : La dirigeante conserve une participation importante (environ 3,3 millions d’actions), renforçant l’alignement des incitations, mais aucun nouvel investissement en espèces n’a été effectué.

Globalement, le dépôt reflète un vesting habituel de compensation en actions et la retenue fiscale associée, plutôt qu’une décision discrétionnaire d’achat ou de vente. L’impact sur le marché est attendu neutre, sauf autres catalyseurs.

Übersicht zur Form 4 Einreichung: Clover Health Investments (CLOV) meldete Insider-Aktivitäten von Jamie L. Reynoso, aufgeführt als „CEO, Medicare Advantage.“ Am 30. Juni 2025 erhielt Frau Reynoso 217.523 Class A Aktien durch die letzte Tranche einer leistungsabhängigen RSU-Zuteilung vom 16. März 2023. Zur Begleichung der Quellensteuer verkaufte das Unternehmen automatisch 85.596 Aktien zu je 2,79 $. Nach dem automatischen Verkauf hält Frau Reynoso direkt 3.328.328 Class A Aktien, etwa 132.000 Aktien mehr als zuvor.

  • Art der Transaktion: Code „A“ steht für Erwerb durch Aktienzuteilung; Code „F“ für zurückbehaltene Aktien zur Steuerzahlung – beides keine offenen Markttransaktionen.
  • Kostenbasis: Die RSUs wurden ohne Barzahlung für den Insider abgewickelt; nur der steuerbedingte Verkauf erfolgte zum Marktpreis.
  • Auswirkung auf Ausrichtung: Die Führungskraft hält eine bedeutende Beteiligung (ca. 3,3 Millionen Aktien), was die Anreizausrichtung stärkt, jedoch wurde keine neue Barinvestition getätigt.

Insgesamt spiegelt die Einreichung eine routinemäßige Aktienvergütung und die damit verbundene Steuerabführung wider, keine diskretionäre Kauf- oder Verkaufsentscheidung. Die Marktauswirkung wird neutral erwartet, sofern keine weiteren Ereignisse eintreten.

10-K/AtrueFY0001923780SC0.50.5Retrospectively restated for the effect of 2-for-1 reverse stock split. (Note 18) 0001923780 2024-01-01 2024-12-31 0001923780 2024-12-31 0001923780 2023-12-31 0001923780 2023-01-01 2023-12-31 0001923780 2023-07-06 2023-07-06 0001923780 2022-05-16 0001923780 2021-12-31 0001923780 2024-06-28 0001923780 2021-07-26 0001923780 2022-12-31 0001923780 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001923780 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001923780 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001923780 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001923780 srt:MaximumMember 2024-01-01 2024-12-31 0001923780 srt:MinimumMember 2024-01-01 2024-12-31 0001923780 currency:HKD 2024-01-01 2024-12-31 0001923780 currency:CNY 2024-01-01 2024-12-31 0001923780 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaOneMember 2024-01-01 2024-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaTwoMember 2024-01-01 2024-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaThreeMember 2024-01-01 2024-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaFourMember 2024-01-01 2024-12-31 0001923780 ncl:BankOfCommunicationsOneMember 2024-01-01 2024-12-31 0001923780 ncl:BankOfCommunicationsTwoMember 2024-01-01 2024-12-31 0001923780 ncl:BankOfAmericaMember 2024-01-01 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankOneMember 2024-01-01 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankTwoMember 2024-01-01 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankThreeMember 2024-01-01 2024-12-31 0001923780 ncl:AgriculturalBankOfChinaChangzhouZhonglouSubbranchMember 2024-01-01 2024-12-31 0001923780 ncl:EIDLLoanMember 2024-01-01 2024-12-31 0001923780 country:HK ncl:TwoTierTaxRateSlabOneMember 2024-01-01 2024-12-31 0001923780 country:CN 2024-01-01 2024-12-31 0001923780 ncl:BenchwickMember country:HK 2024-01-01 2024-12-31 0001923780 country:HK ncl:TwoTierTaxRateSlabTwoMember 2024-01-01 2024-12-31 0001923780 country:HK 2024-01-01 2024-12-31 0001923780 country:US 2024-01-01 2024-12-31 0001923780 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ncl:NoOtherMajorCustomersMember 2024-01-01 2024-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:SupplierConcentrationRiskMember ncl:FiveMajorSuppliersMember 2024-01-01 2024-12-31 0001923780 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember ncl:NoMajorSuppliersMember 2024-01-01 2024-12-31 0001923780 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ncl:FiveMajorCustomersMember 2024-01-01 2024-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ncl:NoOtherMajorCustomersMember 2024-01-01 2024-12-31 0001923780 ncl:NorthannCorpMember 2024-01-01 2024-12-31 0001923780 ncl:SubscriptionReceivableMember 2024-01-01 2024-12-31 0001923780 ncl:RaleighIndustriesLimitedMember 2024-01-01 2024-12-31 0001923780 ncl:CedarModernLimitedMember 2024-01-01 2024-12-31 0001923780 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001923780 us-gaap:OfficeEquipmentMember 2024-12-31 0001923780 ncl:ManufacturingEquipmentMember 2024-12-31 0001923780 currency:HKD 2024-12-31 0001923780 currency:CNY 2024-12-31 0001923780 ncl:ManufacturingEquipmentMember srt:MaximumMember 2024-12-31 0001923780 ncl:ManufacturingEquipmentMember srt:MinimumMember 2024-12-31 0001923780 ncl:OfficeAndComputerEquipmentMember srt:MaximumMember 2024-12-31 0001923780 ncl:OfficeAndComputerEquipmentMember srt:MinimumMember 2024-12-31 0001923780 us-gaap:UseRightsMember 2024-12-31 0001923780 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-12-31 0001923780 ncl:LinLiChiefExecutiveOfficerAndChairmanOfTheBoardMember 2024-12-31 0001923780 ncl:DesignatedSeriesAPreferredStockMember 2024-12-31 0001923780 country:HK 2024-12-31 0001923780 ncl:NorthannCorpMember 2024-12-31 0001923780 ncl:NorthannCorpMember us-gaap:RelatedPartyMember 2024-12-31 0001923780 ncl:NorthannCorpMember us-gaap:SeriesAPreferredStockMember 2024-12-31 0001923780 ncl:NorthannCorpMember us-gaap:CommonStockMember 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankOneMember 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankTwoMember 2024-12-31 0001923780 ncl:JiangnanRuralCommercialBankThreeMember 2024-12-31 0001923780 ncl:AgriculturalBankOfChinaChangzhouZhonglouSubbranchMember 2024-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaOneMember 2024-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaTwoMember 2024-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaThreeMember 2024-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaFourMember 2024-12-31 0001923780 ncl:BankOfCommunicationsOneMember 2024-12-31 0001923780 ncl:BankOfCommunicationsTwoMember 2024-12-31 0001923780 ncl:BankOfAmericaMember 2024-12-31 0001923780 ncl:EIDLLoanMember 2024-12-31 0001923780 ncl:DepositForBankAcceptanceBillMember 2024-12-31 0001923780 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001923780 us-gaap:OfficeEquipmentMember 2023-12-31 0001923780 ncl:ManufacturingEquipmentMember 2023-12-31 0001923780 currency:HKD 2023-12-31 0001923780 currency:CNY 2023-12-31 0001923780 us-gaap:UseRightsMember 2023-12-31 0001923780 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001923780 ncl:LinLiChiefExecutiveOfficerAndChairmanOfTheBoardMember 2023-12-31 0001923780 ncl:NorthannCorpMember 2023-12-31 0001923780 ncl:NorthannCorpMember us-gaap:RelatedPartyMember 2023-12-31 0001923780 ncl:NorthannCorpMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001923780 ncl:NorthannCorpMember us-gaap:CommonStockMember 2023-12-31 0001923780 ncl:JiangnanRuralCommercialBankTwoMember 2023-12-31 0001923780 ncl:JiangnanRuralCommercialBankThreeMember 2023-12-31 0001923780 ncl:AgriculturalBankOfChinaChangzhouZhonglouSubbranchMember 2023-12-31 0001923780 ncl:BankOfCommunicationsTwoMember 2023-12-31 0001923780 ncl:BankOfAmericaMember 2023-12-31 0001923780 ncl:JiangnanRuralCommercialBankOneMember 2023-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaTwoMember 2023-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaThreeMember 2023-12-31 0001923780 ncl:BankOfCommunicationsOneMember 2023-12-31 0001923780 ncl:IndustrialAndCommercialBankOfChinaOneMember 2023-12-31 0001923780 ncl:IndustrialandCommercialBankofChinaFourMember 2023-12-31 0001923780 ncl:EIDLLoanMember 2023-12-31 0001923780 ncl:DepositForBankAcceptanceBillMember 2023-12-31 0001923780 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001923780 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001923780 us-gaap:CommonStockMember us-gaap:IPOMember 2023-01-01 2023-12-31 0001923780 currency:HKD 2023-01-01 2023-12-31 0001923780 currency:CNY 2023-01-01 2023-12-31 0001923780 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ncl:NoOtherMajorCustomersMember 2023-01-01 2023-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:SupplierConcentrationRiskMember ncl:NoMajorSuppliersMember 2023-01-01 2023-12-31 0001923780 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember ncl:OneMajorSuppliersMember 2023-01-01 2023-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ncl:TwoMajorCustomersMember 2023-01-01 2023-12-31 0001923780 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ncl:FiveMajorCustomersMember 2023-01-01 2023-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:SupplierConcentrationRiskMember ncl:ThreeMajorSuppliersMember 2023-01-01 2023-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ncl:NoOtherMajorCustomersMember 2023-01-01 2023-12-31 0001923780 ncl:NorthannCorpMember 2023-01-01 2023-12-31 0001923780 us-gaap:IPOMember 2023-01-01 2023-12-31 0001923780 us-gaap:AdditionalPaidInCapitalMember us-gaap:IPOMember 2023-01-01 2023-12-31 0001923780 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ncl:TwoMajorCustomersMember 2022-01-01 2022-12-31 0001923780 us-gaap:OverAllotmentOptionMember 2023-10-23 0001923780 us-gaap:IPOMember 2023-10-23 0001923780 ncl:ConvertibleDebenturesMember 2022-05-16 0001923780 country:US 2020-03-27 0001923780 ncl:ReverseSplitMember 2023-07-05 0001923780 ncl:ReverseSplitMember 2023-07-06 0001923780 ncl:SecuredBorrowingArrangementMember 2023-07-01 2023-07-31 0001923780 ncl:SecuredBorrowingArrangementMember 2023-07-31 0001923780 ncl:LoanAgreementMember 2025-01-21 0001923780 ncl:LoanAgreementMember us-gaap:SubsequentEventMember 2025-01-21 0001923780 ncl:PromissoryNoteMember us-gaap:SubsequentEventMember 2025-01-27 0001923780 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2025-01-27 0001923780 ncl:PromissoryNoteMember us-gaap:SubsequentEventMember 2025-01-27 2025-01-27 0001923780 ncl:CedarModernLimitedMember 2024-10-31 0001923780 ncl:RaleighIndustriesLimitedMember 2024-11-30 0001923780 us-gaap:CommonStockMember 2025-06-30 0001923780 us-gaap:SeriesAPreferredStockMember 2025-06-30 0001923780 ncl:NewivyFlooringMember 2025-06-30 0001923780 us-gaap:CommonStockMember 2024-12-31 0001923780 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001923780 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001923780 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001923780 us-gaap:RetainedEarningsMember 2024-12-31 0001923780 ncl:SubscriptionReceivableMember 2024-12-31 0001923780 us-gaap:CommonStockMember 2022-12-31 0001923780 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001923780 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001923780 us-gaap:RetainedEarningsMember 2022-12-31 0001923780 ncl:SubscriptionReceivableMember 2022-12-31 0001923780 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001923780 ncl:NorthannCorpMember 2022-12-31 0001923780 us-gaap:CommonStockMember 2023-12-31 0001923780 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001923780 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001923780 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001923780 us-gaap:RetainedEarningsMember 2023-12-31 0001923780 ncl:SubscriptionReceivableMember 2023-12-31 xbrli:shares iso4217:USD xbrli:pure utr:Year iso4217:HKD utr:sqm utr:Month iso4217:USD xbrli:shares ncl:Customers ncl:Suppliers
 
 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form
10-K
/A

(Amendment No. 1)
 
(Mark One)
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2024
 
OR
 
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______ to ________
 
Commission file number: 001-41816
 
NORTHANN CORP.
(Exact name of registrant as specified in its charter)
 
Nevada
88-1513509
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
 
2251 Catawba River Rd
Fort Lawn,
SC
29714
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code: 
(916) 573 3803
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading Symbol(s)
 
Name of Each Exchange on Which

Registered
Common Stock, with par value of $0.001
 
NCL
 
NYSE American
 
Securities registered pursuant to Section 12(g) of the Act: None.
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  
  No  
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes  
  No  
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  
  No  
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  
  No  
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “emerging growth company” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
 
Accelerated filer
 
Non-accelerated filer
 
 
Smaller reporting company
 
 
 
 
Emerging growth company
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  
 
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.    
 
Indicate by check mark whether any of those error corrections are restatements that require a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D(b).  
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  
  No  
 
The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant as of June 28, 2024, the last business day of the registrant's most recently completed second fiscal quarter, was $
 
2,335,761 based upon the closing price reported for such date on the NYSE American.
 
On
June 30, 2025
, the registrant had 95,464,400 shares of common stock and 5,000,000 shares of Series A Preferred Stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE: None

 
 
 
 
EXPLANATORY NOTE
 
This Amendment No. 1 on Form 10-K/A (this “Amendment”) to the Annual Report on Form 10-K of Northann Corp. (the “Company”) for the fiscal year ended December 31, 2024, initially filed with the Securities and Exchange Commission (the “SEC”) on July 1, 2025 (the “Original Filing”), is being filed to add to the Original Filing the Report of LAO Professionals (“New Auditor Report”), on our consolidated financial statements as of December 31, 2024, which was inadvertently omitted from the Original Filing. The Company had received the manually signed New Auditor Report from LAO Professionals prior to filing the Original Filing. This Amendment includes Item 8, “Financial Statements and Supplemental Data” in its entirety and without change from the Original Filing other than the addition of the New Auditor Report as the new page F-3, and the updating of page references.
 
 
In addition, pursuant to the rules of the SEC, the exhibit list included in Item 15 of Part IV of the Original Filing has been amended to contain currently-dated certifications from the Company’s Chief Executive and Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002, and currently-dated certifications from the Company’s Chief Executive and Financial Officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002. The certifications of the Company’s Chief Executive and Financial Officer are filed as exhibits to this Amendment.
 
Additionally, the Commission file number set out on the cover page in the Original Filing was inaccurate due to an inadvertent clerical error, and the Company is also filing this Amendment to reflect the accurate Commission file number.
 
This Form 10-K/A does not reflect events occurring after the Original Filing and does not modify or update the disclosure therein in any way except as described above. No other changes have been made to the Original Filing. The filing of this Form 10-K/A should not be understood to mean that any statements contained in the Original Filing, as amended by this Form 10-K/A, are true or complete as of any date subsequent to the date of the Original Filing. Accordingly, this Form 10-K/A should be read in conjunction with the Original Filing and with our filings made with the SEC subsequent to July 1, 2025, if any.
 
PART II
 
ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA
 
The information required by this item appears beginning on page F-1
 
following the signature pages of this report and is incorporated herein by reference.
 
2
 

PART IV
 
ITEM 15.
EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES
 
Exhibit
Number
 
 
Description
3.1
Articles of Incorporation (incorporated by reference to Exhibit 3.1 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
3.2
 
Certificate of Amendment to the Articles of Incorporation (incorporated by reference to Exhibit 3.2 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
3.3
Certificate of Designation of Series A Preferred Stock (incorporated by reference to Exhibit 3.3 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
3.4
Certificate of Amendment to the Certificate of Designation of Series A Preferred Stock (incorporated by reference to Exhibit 3.4 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
3.5
Bylaws (incorporated by reference to Exhibit 3.5 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
4.5
Description of Securities (incorporated by reference to Exhibit 4.5 of our Annual Report on Form 10-K (File No. 001-41816), filed with the Securities and Exchange Commission on July 1, 2025)
10.1
Employment Agreement between the Company and Lin Li dated July 1, 2022 (incorporated by reference to Exhibit 10.2 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
10.2
Employment Agreement between the Company and Kurtis W. Winn dated July 1, 2022 (incorporated by reference to Exhibit 10.4 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
10.3
English translation of the Construction Agreement between NCP and Changzhou Wanyuan Construction Engineering Co., dated July 26, 2021 (incorporated by reference to Exhibit 10.12 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
10.4
 
English Translation of Form of Loan Agreement by and between NCP and Industrial and Commercial Bank of China dated June 4, 2024 (Contract No. 2024 (Wujin) Zi 00690) (incorporated by reference to Exhibit 10.4 of our Registration Statement on Form S-1 (File No. 333-284033), as amended, initially filed with the Securities and Exchange Commission on January 14, 2025)
10.5
 
English Translation of Form of Loan Agreement by and between NCP and Industrial and Commercial Bank of China dated June 4, 2024 (Contract No. 2024 (Wujin) Zi 00957) (incorporated by reference to Exhibit 10.5 of our Registration Statement on Form S-1 (File No. 333-284033), as amended, initially filed with the Securities and Exchange Commission on January 14, 2025)
10.6
 
English Translation of Loan Agreement by and between NCP and Jiangnan Rural Commercial Bank entered on March 26, 2020 (incorporated by reference to Exhibit 10.6 of our Registration Statement on Form S-1 (File No. 333-284033), as amended, initially filed with the Securities and Exchange Commission on January 14, 2025)
10.7
2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.17 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
10.8
Lease Agreement, dated July 26, 2024  and amended as of August 5, 2024,  among Northann Corp. and SKY SC LLC (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on August 5, 2024)
 

3
  
10.9
Share Purchase Agreement, dated as of October 11, 2024, by and between Northann Corp .and Chuntao Li (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on October 15, 2024)
10.10
Share Purchase Agreement by and between the Company and Jianquan Xu dated November 13, 2024 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on November 15, 2024)
10.11
First Amendment of Lease, dated November 19, 2024, among Northann Corp. and SKY SC LLC (incorporated by reference to Exhibit 10.2 of our Current Report on Form 8-K filed with the SEC on November 21, 2024)
10.12
Financing and Strategic Planning Advisory Agreement by and between the Company and Linkun Investment LLC dated December 4, 2024 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on December 5, 2024)
10.13
Business Development Agreement by and between the Company and CAKL Holdings Sdn Bhd dated December 4, 2024 (incorporated by reference to Exhibit 10.2 of our Current Report on Form 8-K filed with the SEC on December 5, 2024)
 
 
 
10.14
Technical Service Agreement by and between the Company and San River International Sdn Bhd dated December 4, 2024 (incorporated by reference to Exhibit 10.3 of our Current Report on Form 8-K filed with the SEC on December 5, 2024)
10.15
Form of Share Purchase Agreement by and between the Company and Oneflow LLC as the lead investor and other investors dated December 6, 2024 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on December 6, 2024)
10.16
Form of Registration Rights Agreement by and between the Company and Oneflow LLC as the lead investor and other investors dated December 6, 2024 (incorporated by reference to Exhibit 10.2 of our Current Report on Form 8-K filed with the SEC on December 6, 2024)
10.17
Form of Share Purchase Agreement by and between the Company and X29 LLC as the lead investor and other investors dated December 6, 2024 (incorporated by reference to Exhibit 10.3 of our Current Report on Form 8-K filed with the SEC on December 6, 2024)
10.18
Form of Registration Rights Agreement by and between the Company and X29 LLC as the lead investor and other investors dated December 6, 2024 (incorporated by reference to Exhibit 10.4 of our Current Report on Form 8-K filed with the SEC on December 6, 2024)
10.19
Form of Share Purchase Agreement by and between the Company and Caitlin Xu Kang as the lead investor and other investors dated December 20, 2024 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on December 23, 2024)
10.20
EB-5 Loan Agreement dated January 21, 2025, between 3D PRINTING DEV, LLC and 3DFLOR OPPORTUNITY, LP (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on March 5, 2025)
10.21
Promissory Note issued by 3D PRINTING DEV, LLC on January 27, 2025 (incorporated by reference to Exhibit 10.2 of our Current Report on Form 8-K filed with the SEC on March 5, 2025)
10.22
Membership Interest Pledge Agreement dated January 27, 2025, by and among Benchwick LLC, 3DFLOR OPPORTUNITY, LP and 3D PRINTING DEV, LLC (incorporated by reference to Exhibit 10.3 of our Current Report on Form 8-K filed with the SEC on March 5, 2025)
14.1
Code of Business Conduct and Ethics of the Company (incorporated by reference to Exhibit 10.16 of our Registration Statement on Form S-1 File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
14.2
 
Insider Trading Policy (incorporated by reference to Exhibit 14.2 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
21.1

List of Subsidiaries (incorporated by reference to Exhibit 21.1 of our Annual Report on Form 10-K (File No. 001-41816), filed with the Securities and Exchange Commission on July 1, 2025)
23.1
Consent of WWC, P.C. (incorporated by reference to Exhibit 23.1 of our Annual Report on Form 10-K (File No. 001-41816), filed with the Securities and Exchange Commission on July 1, 2025)
23.2
Consent of LAO Professionals(incorporated by reference to Exhibit 23.2 of our Annual Report on Form 10-K (File No. 001-41816), filed with the Securities and Exchange Commission on July 1, 2025)
 
4
 
31.1*
 
Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer
31.2*
 
Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial officer
32.1*

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 
32.2*

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
97.1
Clawback Policy (incorporated by reference to Exhibit 97.1 of our Annual Report on Form 10-K filed with the SEC on April 15, 2024)
99.1
Audit Committee Charter (incorporated by reference to Exhibit 99.2 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
99.2
Nominating Committee Charter (incorporated by reference to Exhibit 99.3 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
99.3
Compensation Committee Charter (incorporated by reference to Exhibit 99.44 of our Registration Statement on Form S-1 (File No. 333-273246), as amended, initially filed with the Securities and Exchange Commission on July 14, 2023)
101.INS
*
 
XBRL INSTANCE DOCUMENT
101.SCH
*
 
XBRL TAXONOMY EXTENSION SCHEMA
101.CAL
*
 
XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF
*
 
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB
*
 
XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE
*
 
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
 
*
Filed herewith
 
5
 
SIGNATURES
 
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
NORTHANN CORP.
 
 
Dated:  July 2, 2025
By:
/s/
Lin Li
 
 
Lin Li
 
 
Chairman of the Board, Chief Executive Officer,
President, Secretary, and Treasurer
 

6
INDEX TO FINANCIAL STATEMENTS
Consolidated Financial Statements for the Fiscal Years Ended December 31, 2024 and 2023
 
Reports of Independent Registered Accounting Firm
F-2
 
Consolidated Balance Sheets as of December 31, 2024 and 2023
F-4
 
Consolidated Statements of Income and Comprehensive Income (Loss) for the Years Ended December 31, 2024 and 2023
F-5
 
Consolidated Statements of Stockholders’ Deficit for the years ended December 31, 2024 and 2023
F-6
 
Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023
F-7
 
Notes to Consolidated Financial Statements
F-8
F-1
 
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Northann Corp.
 
Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of
Northann Corp
. (the ‘Company’) as of December 31, 2024, and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2024, and the results of its consolidated operations and its cash flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.
 
Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1, the Company suffered an accumulated deficit of $(9,693,818) and a net loss of $(4,379,875). These matters raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans with regards to these matters are also described in Note 1 to the financial statements. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
 
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. Communication of critical audit matters does not alter in any way our opinion on the financial statements taken as a whole and we are not, by communicating the critical audit matters, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.
 
Impairment of intangible assets
 
Description of the Matter
 
As discussed in Note 1 to the consolidated financial statements, intangible assets including goodwill are tested for impairment on an annual basis, or more frequently if the Company believes indicators of impairment exist. The Company measured the fair value of these intangible assets based on projected cash flows and combined with other qualitative factors, the Company determined that some portion of the intangible assets are impaired as of December 31, 2024.
 
Auditing the Company’s annual impairment test related to these intangible assets was complex due to the estimation uncertainty in determining their fair values. The significant assumptions used to estimate the fair value of these intangible assets included forecasted sales and discount rates. These assumptions are forward-looking which can vary significantly and depend on market forces and events outside of the Company’s control.
 
How We Addressed the Matter in Our Audit
 
To test the estimated fair value of these intangible assets, our audit procedures included, among others, evaluating the valuation methodology used, the significant assumptions discussed above, and the underlying data used by the Company. Such data includes historical sales and projections. We reviewed the assumptions and data provided by management and concluded that the impairment recorded was reasonable.
 
/S/ Lateef Awojobi
 
LAO PROFESSIONALS
 
(PCAOB ID 7057)
 
Lagos, Nigeria
 
 
We have served as the Company’s auditor since 2025.
 
June 30, 2025
 
 
F-2
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
 
To:
The Board of Directors and Stockholders of Northann Corp.
 
Opinion on the Financial Statements
 
We have audited the accompanying consolidated balance sheets of Northann Corp. and its subsidiaries (collectively the “Company”) as of December 31, 2023, and the related consolidated statements of income and comprehensive income (loss), stockholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.
 
Emphasis of Matter – Going Concern
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of December 31, 2022, the Company had a working capital deficit that factors gave rise to substantial doubt that the Company would continue as a going concern. As of December 31, 2023, the Company had net positive stockholders’ equity position, but the Company still had a working capital deficit; accordingly, the Company had not alleviated the substantial doubt that it would continue as a going concern. Management closely monitors the Company’s financial position and result of operations and has prepared a plan that includes raising additional capital and implementing improvements to increase profitability to address this substantial doubt. Details of this plan are also found in Note 1. These financial statements do not include any adjustments that might result from the outcome of this uncertainly.
 
Basis for Opinion
 
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal controls over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal controls over financial reporting. Accordingly, we express no such opinion.
 
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 

WWC, P.C.
Certified Public Accountants
PCAOB ID: 1171
 
We have served as the Company’s auditor since 2021.
San Mateo, California
April 15, 2024


F-3

 
 
NORTHANN CORP.
 
CONSOLIDATED BALANCE SHEETS
AS OF DECEMBER 31, 202
4
AND 202
3
(In U.S. dollars)
 
 
 
202
4
 
 
202
3
 
 
 
 
 
 
 
 
ASSETS
 
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
 
 
Cash
 
$
245,164
 
 
$
1,101,443
 
Restricted cash
 
 
-
 
 
 
3,771
 
Accounts receivable, net
 
 
3,106,561
 
 
 
2,615,458
 
Inventory, net
 
 
1,995,611
 
 
 
2,645,488
 
Prepayments
 
 
490,948
 
 
 
311,402
 
Other receivables and other current assets
 
 
74,984
 
 
 
127,313
 
Total current assets
 
 
5,913,268
 
 
 
6,804,875
 
 
 
 
 
 
 
 
 
 
NON-CURRENT ASSETS
 
 
 
 
 
 
 
 
Property, plant and equipment, net
 
 
3,894,434
 
 
 
4,724,105
 
Construction in progress
 
 
1,258,701
 
 
 
962,338
 
Intangible assets
, net
 
 
977,986
 
 
 
1,030,982
 
Operating lease right-of-use assets, net
 
 
1,822,266
 
 
 
87,380
 
Security deposits
 
 
9,030
 
 
 
9,030
 
Total non-current assets
 
 
7,962,417
 
 
 
6,813,835
 
 
 
 
 
 
 
 
 
 
TOTAL ASSETS
 
$
13,875,685
 
 
$
13,618,710
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CURRENT LIABILITIES
 
 
 
 
 
 
 
 
Bank borrowings - current
 
 
4,699,081
 
 
 
5,689,721
 
Operating lease liabilities, current
 
 
355,754
 
 
 
31,413
 
Accounts and other payables and accruals
 
 
2,600,469
 
 
 
4,538,322
 
Taxes payable
 
 
601,317
 
 
 
608,679
 
Unearned revenue
 
 
-
 
 
1,084,484
 
Amounts due to related parties
 
 
1,416,432
 
 
 
302,943
 
Obligation under secured borrowing arrangement
 
 
-
 
 
 
599,664
 
Total current liabilities
 
 
9,673,053
 
 
 
12,855,226
 
 
 
 
 
 
 
 
 
 
Bank borrowings – non-current
 
 
136,947
 
 
 
124,905
 
Operating lease liabilities, – non-current
 
 
1,466,512
 
 
 
55,967
 
Total non-current liabilities
 
 
1,603,459
 
 
 
180,872
 
 
 
 
 
 
 
 
 
 
TOTAL LIABILITIES
 
$
11,276,512
 
 
$
13,036,098
 
 
 
 
 
 
 
 
 
 
COMMITMENTS AND CONTINGENCIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STOCKHOLDERS’ EQUITY (DEFICIT)
 
 
 
 
 
 
 
 
Preferred stock, 100,000,000 shares authorized – Series A, $0.001 par value, 20,000,000 shares designated, 5,000,000 shares issued and outstanding as of December 31, 202
4
and 202
3
*
 
 
5,000
 
 
 
5,000
 
Common stock, $0.001 par value, 400,000,000 shares authorized, 55,464,000 and 21,380,000 shares issued and outstanding as of December 31, 202
4
and 202
3
, respectively*
 
 
55,464
 
 
 
21,380
 
Subscription receivable
 
 
(1,375,000
)
 
 
(25,000
)
Accrued compensation expense
 
 
(2,927,250
)
 
 
 
 
Additional paid-in capital
 
 
15,487,165
 
 
 
6,671,016
 
Accumulated deficits
 
 
(9,693,818
)
 
 
(5,313,943
)
Accumulated other comprehensive loss
 
 
1,047,612
 
 
(775,841
)
Total stockholders’ equity
 
 
2,599,173
 
 
582,612
 
 
 
 
 
 
 
 
 
 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
 
$
13,875,685
 
 
$
13,618,710
 
  
The accompanying notes are an integral part of these consolidated financial statements.
 
 
*
Retrospectively restated for the effect of 2-for-1 reverse stock split.
 (Note 1
8
)
 
 
F-4
 
 
NORTHANN CORP. 
CONSOLIDATED STATEMENTS OF
OPERATIONS
AND COMPREHENSIVE LOSS
FOR THE YEARS ENDED DECEMBER 31, 202
4
AND 202
3
(In U.S. dollars)
 
 
 
202
4
 
 
202
3
 
 
 
 
 
 
 
 
REVENUES
 
$
15,349,854
 
 
$
13,971,729
 
 
 
 
 
 
 
 
 
 
COST OF REVENUES
 
 
11,370,028
 
 
 
12,744,474
 
 
 
 
 
 
 
 
 
 
GROSS PROFIT
 
 
3,979,826
 
 
 
1,214,364
 
 
 
 
 
 
 
 
 
 
OPERATING EXPENSES
 
 
 
 
 
 
 
 
Selling expenses
 
 
1,071,633
 
 
 
1,158,467
 
General and administrative expenses
 
 
3,798,777
 
 
 
2,920,303
 
Research and development expenses
 
 
783,356
 
 
 
1,899,299
 
Total operating expenses
 
 
5,653,766
 
 
 
5,978,069
 
 
 
 
 
 
 
 
 
 
LOSS
FROM OPERATIONS
 
 
(1,673,940
)
 
 
(4,763,705
)
 
 
 
 
 
 
 
 
 
OTHER INCOME (EXPENSE)
 
 
 
 
 
 
 
 
Interest expense
 
 
(470,900
)
 
 
(1,709,983
)
Amortization of debt discounts
 
 
-
 
 
 
(645,576
)
Other income
 
 
306,404
 
 
 
1,052
 
Other expenses
 
 
(32,371
)
 
 
-
 
Impairment loss on goodwill
 
 
(2,507,455
)
 
 
-

Interest income
 
 
120
 
 
-
 
Total other expenses
,
 net
 
 
(2,704,202
)
 
 
(2,354,507
)
 
 
 
 
 
 
 
 
 
LOSS
 
BEFORE TAXES
 
 
(4,378,142
)
 
 
(7,118,212
)
 
 
 
 
 
 
 
 
 
Income tax expense
 
 
(1,733
)
 
 
(14,361
)
 
 
 
 
 
 
 
 
 
NET
LOSS
 
 
(4,379,875
)
 
 
(7,132,573
)
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
 
 
1,823,453
 
 
 
(5,950
)
 
 
 
 
 
 
 
 
 
Total comprehensive loss
 
 
(2,556,422
)
 
 
(7,138,523
)
 
 
 
 
 
 
 
 
 
Basic and diluted
loss
per share
 
$
(0.17
)
 
$
(0.35
)
 
 
 
 
 
 
 
 
 
Weighted average number of shares of common stock outstanding – basic
 
 
26,267,990
 
 
 
20,278,226
 
Weighted average number of shares of common stock outstanding –diluted
 
 
26,267,990
 
 
 
20,278,226
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-5
 
 
NORTHANN CORP.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
FOR
THE YEARS ENDED DECEMBER 31, 2024
AND
2023
(In U.S. dollars)
 
 
Preferred Stock –
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Series A
 
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of
shares*
 
 
 
 
Amount
 
 
Number of
shares*
 
 
 
 
Amount
 
 
Subscription
receivable
 
 
 
 
Additional
paid in
capital
 
 
 
 
 
 
Retained
earnings
 
 
 
 
Accumulated
other
comprehensive
loss
 
 
 
 
 
 
 
 
Total
 
Balance, December 31, 2022
 
 
5,000,000
 
 
 
5,000


20,000,000
 
 
 
20,000
 
 
 
(25,000
)
 
$
925,000
 
 
 
1,818,630
 
 
 
(769,891
)
 
$
1,973,739
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net
loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
(7,132,573
)
 
 
-
 
 
 
(7,132,573
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(5,950
)
 
 
(5,950
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
-
 
 
 
-
 
 
 
 
 
Issuance of ordinary shares
upon the completion of the IPO
 
 
 
 
 
 
 
 
 
 
1,380,000
 
 
 
1,380
 
 
 
 
 
 
 
5,746,016
 
 
 
 
 
 
 
 
 
 
 
5,747,396
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2023
 
 
5,000,000
 
 
 
5,000
 
 
 
21,380,000
 
 
 
21,380
 
 
 
(25,000
)
 
$
6,671,016
 
 
 
(5,313,943
)
 
 
(775,841
)
 
 
582,612
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net
loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4,379,875
)
 
 
 
 
 
 
(4,379,875
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Issuance of common stock
 
 
 
 
 
 
 
 
 
 
34,084,000
 
 
 
34,084
 
 
 
(1,350,000
)
 
 
8,816,149
 
 
 
 
 
 
 
 
 
 
 
7,500,233
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acc
ru
ed
compensation expense

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2,927,250
)
 
 
 
 
 
 
 
 
 
 
(2,927,250
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,823,453
 
 
 
1,823,453
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2024
 
 
5,000,000
 
 
 
5,000
 
 
 
55,464,000
 
 
 
55,464
 
 
 
(1,375,000
)
 
 
12,559,915
 
 
 
(9,693,818
)
 
 
1,047,612
 
 
2,599,173
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
*
Retrospectively restated for the effect of 2-for-1 reverse stock split. 
(Note 1
8
)
 
 
F-6
 
 
NORTHANN CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 202
4
AND 202
3
(In U.S. dollars)
 
 
 
202
4
 
 
202
3
 
 
 
 
 
 
 
 
Cash flows from operating activities
 
 
 
 
 
 
 
 
Net
loss
 
$
(4,379,875
)
 
$
(7,132,573
)
Adjustments to reconcile net loss to cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
 
-
 
 
 
13,891
 
Depreciation and amortization
 
 
645,493
 
 
 
680,166
 
Impairment of Property, plant and equipment
 
 
-
 
 
 
-
 
 
Inventory write down
 
 
-
 
 
 
-
 
 
Impairment of goodwill
 
 
2,507,455
 
 
 
-
 

 
I
ncome
fr
om
settlement of convertible notes
 
 
(250,000
)
 
 
-
 
 
Share-based compensation
 
 
2,042,105
 
 
 
-
 
 
Changes in assets and liabilities
 
 
 
 
 
 
 
 
Accounts receivable
 
 
(491,103
)
 
 
(1,186,720
)
Other receivables
 
 
52,328
 
 
(16,019
)
Prepayments
 
 
(179,546
)
 
 
(74,835
)
Inventory
 
 
649,877
 
 
 
1,916,878
 
Right of use assets
 
 
(1,734,886
)
 
 
(69,140
)
Accounts payable
 
 
(41,968
)
 
 
(2,381,174
)
Accruals and other payables
 
 
(711,533
)
 
 
1,827,143
 
Unearned revenue
 
 
(1,084,484
)
 
 
1,084,197
 
Payroll payable
 
 
5,888
 
 
 
51,483
 
Taxes payable
 
 
(7,362
)
 
 
 
 
538,403
 
Accrued interest
 
 
9,234
 
 
 
444
 
Operating leases
 
 
1,734,886
 
 
 
69,140
 
Net cash used in operating activities
 
 
(1,233,491
)
 
 
(4,678,716
)
Cash flows from investing activities
 
 
 
 
 
 
 
 
Payments for construction
 
 
(296,363
)
 
 
 
 
-
 
Net cash used in investing activities
 
 
(296,363
)
 
 
 
 
-
 
Cash flows from financing activities
 
 
 
 
 
 
 
 
Proceeds from bank borrowings
 
 
726,099
 
 
 
-
 
Payment of  Bank Loan
 
 
(1,704,697
)
 
 
(1,307,808
)
Amount received from secured borrowing arrangement
 
 
-


 
 
 
 
599,664
 
Payment of secured borrowing arrangement
 
 
(844,900
)
 
 
-

 
Settlement of convertible notes
 
 
(500,000
)
 
 
-
 
Amounts received from related party
 
 
1,136,913
 
 
 
118,883
 
Net proceeds from issuance of ordinary shares upon IPO
 
 
-


 
 
 
 
5,965,750
 
Net cash
(used in)
provided by financing activities
 
 
(1,186,585
)
 
 
5,376,489
 
 
 
 
 
 
 
 
 
 
Effect of exchange rates on cash
 
 
1,856,389
 
 
 
152,506
 
 
 
 
 
 
 
 
 
 
Net change in cash
 
and restricted cash
 
 
(860,050
)
 
 
850,279
 
 
 
 
 
 
 
 
 
 
Cash
and restricted cash
at beginning of year
 
 
1,105,214
 
 
 
254,935
 
 
 
 
 
 
 
 
 
 
Cash
and restricted cash
at end of year
 
$
245,164
 
 
$
1,105,214
 
 
 
 
 
 
 
 
 
 
Supplemental of cash flow information
 
 
 
 
 
 
 
 
Cash paid for interest expenses
 
$
246,140
 
 
$
255,229
 
Cash paid for income tax
 
$
120,525
 
 
$
286,762
 
 
The
accompanying
notes are an integral part of these consolidated financial statements.
 
 
F-7
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31 202
4
AND 202
3
(In U.S. dollars)
 
1.
ORGANIZATION AND BUSINESS
 
The Company commenced operations in August 2013 with the establishment of Northann Building Solutions LLC. (“NBS”) in Delaware. In December 2013, Northann (Changzhou) Construction Products Ltd (“NCP”) was established in China. All of its products were manufactured through NCP.
 
In March 2014, Benchwich Construction Products Ltd (“Benchwick”) was established in Hong Kong. All wholesales to distributors are conducted through Benchwick.
 
In April 2014, Changzhou Macro Merit International Trading Co., Ltd. (“MARCO”) was established in China. All the import/export of our products are conducted through MARCO.
 
In February 2016, Northann Distribution Center Inc. (“NDC”) was established in California. NDC is a distribution center in the United States and maintains a small inventory for retail sales.
 
In September 2017, Changzhou Ringold International Trading Co., Ltd. (“Ringold”) was established in China. All of the raw material are procured from third parties through Ringold.
 
In September 2018, Crazy Industry (Changzhou) Industry Technology Co., Ltd. (“Crazy Industry”) was established in China. Crazy Industry is the research and development hub.
 
In June 2020, Dotfloor Inc. (“Dotfloor”) was established in California. Dotfloor operates dotfloor.com, the online store that offers our vinyl flooring products to retail customers in the United States.
 
In March 2022, Northann Corp. (“Northann”), the current ultimate holding company, was incorporated in Nevada as part of the restructuring transactions in contemplation of our initial public offering. In connection with its incorporation, in April 2022, we completed a share swap transaction and issued common stock and Series A Preferred Stock of Northann to the then existing shareholders of NBS, based on their then respective equity interests held in NBS. NBS then became our wholly owned subsidiary.  In accordance to ASC 805-50-30-5 and ASC 805-50-45-1 through 45-5, the series of restructuring transactions have been accounted for as transactions between entities under common control; accordingly, the Company’s historical capital structure has been retroactively restated to the first period presented. 
 
On October 23, 2023, the Company consummated the initial public offering (the “IPO”) of 1,200,000 
shares of common stock, par value $0.001 per share at an offering price of $5.00  per share. On October 25, 2023, the underwriters of the IPO fully exercised the over-allotment option granted by the Company and purchased additional 180,000 shares of Common Stock at $5.00 per share. The closing of the Over-Allotment Option took place on October 26, 2023.
 

In
October and November
2024, the Company acquired
Cedar Modern Limited
and
Raleigh Industries Limited
(Note 3).

Going Concern
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of December 31, 202
4
, the Company had a working capital deficit of $
3,754,617
and net cash
provided by
operating activities of
only
 
$
1,214,139
for the year ended December 31, 202
4
. The Company may not have adequate liquidity to remain solvent and settle its obligations when payment become due; these factors gave rise to substantial doubt that the Company would continue as a going concern. Management is closely monitoring its financial position, especially its working capital and cash position, as well as its gross profit margins where its positive results of operations will allow the Company to continue as going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainly.
 
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Presentation
 
The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), and include the assets, liabilities, revenues, expenses and cash flows of all subsidiaries. All significant inter-company transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.
 
Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.
 
Use of Estimates
 
The preparation of these consolidation financial statements requires management of the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an on-going basis, the Company evaluates its estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Identified below are the accounting policies that reflect the Company’s most significant estimates and judgments, and those that the Company believes are the most critical to fully understanding and evaluating its consolidated financial statements.
 
 
F-8
 
 
In March 2020 the World Health Organization declared coronavirus COVID-19 a global pandemic. The COVID-19 pandemic has negatively impacted the global economy, workforces, customers, and created significant volatility and disruption of financial markets. The pandemic may impact Company’s future estimates including, but not limited to, our a
l
lowance for doubtful accounts, inventory valuations, fair value measurements, asset impairment charges. It is not possible for the Company to predict the duration or magnitude of the adverse results of the pandemic and its effects on its business or results of operations at this time.
 
Basis of Consolidation
 
The consolidated financial statements include the financial statements of the Company.
 
Revenue Recognition
 
The Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The Company recognizes revenues following the five-step model prescribed under ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) the Company satisfies the performance obligation.
 
Revenue for sales of products which are primarily comprised of hardwood floors and three-dimensional printed flooring are recognized at the time of delivery of the products set forth in contracts with customers. At the time of delivery, physical and legal control of the asset is passed from the Company to its customer, at which time the Company believes it has satisfied the single performance obligation to complete a sales transaction in order to recognize revenue. The Company’s contracts do not allow for returns, refunds, or warranties; however, it is customary in the industry to manufacturers to ship a small portion of extra product to allow for product quality issues. Also, as matter of good business practice, under very specific situations, the Company has historically agreed to provide minor discounts to customers who made complaints on products purchased. The Company has recorded these costs as period expenses when incurred as the Company is not able to reliably estimate such future expenses.
 
Revenues are recognized when control of the promised goods or services is transferred to our customers, which may occur at a point in time or over time depending on the terms and conditions of the agreement, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.
 
Practical expedients and exemption
 
The Company has not incurred any costs to obtain contracts and does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.
 
The Company typically enters into agreements with its customers where its set forth the product to be sold, the price, payment terms, and any antecedent terms such as shipping and delivery specifications; these terms and conditions are most typically specified in purchase order issued by its customers to the Company. The Company typically recognizes revenue at point in time, which is when physical possession and legal title are transferred to the customer, this may be a shipping port or a specified destination; at this point the Company reasonably expect to paid for the product, or in the event where it was paid advance, the Company’s performance obligations have been satisfied and those funds are considered earned by the Company. If the Company sells products on account to customers, they are typically paid within 90 days. Any funds received in advance for the products yet to be transferred to its customer are contract liabilities that are recorded as unearned revenue on the Company’s consolidated balance sheets. $
1,925,349
and $1,084,484 were recognized as revenue from unearned revenue during the years ended December 31,
2024 and 2023
.
 
 
F-9
 
 
Taxation
 
The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not that these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.
 
Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. Penalties and interest incurred related to underpayment of income tax are classified as income tax expense in the year incurred. GAAP also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures and transition. 
 
On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was enacted by the U.S. government which included a wide range of tax reform affecting businesses including the corporate tax rates, international tax provisions, tax credits and deduction with majority of the tax provision effective after December 31, 2017. Certain activities conducted in foreign jurisdictions may result in the imposition of U.S. corporate income taxes on the Company when its subsidiaries, controlled foreign corporations (“CFCs”), generate income that is subject to Subpart F or GILTI under the U.S. Internal Revenue Code beginning after December 31, 2017.
 
 
F-10
 
 
The Coronavirus Aid, Relief and Economy Security (CARES) Act (“the CARES Act, H.R. 748”) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carry backs for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a material impact on its financial statements as of December 31,
2024 and 2023
due to the recent enactment.
 
The Company accounts for an unrecognized tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities. The Company considers and estimates interest and penalties related to the gross unrecognized tax benefits and includes as part of its income tax provision based on the applicable income tax regulations.
 
The Company did not accrue any liability, interest or penalties related to uncertain tax positions in the provision for income taxes line of the consolidated statements of operations for the year ended December 31, 202
4
. The Company had no uncertain tax position for the years ended December 31, 202
4
and 202
3
.
 
Foreign Currency and Foreign Currency Translation
 
The functional currency of the Company is the Chinese Yuan (“RMB”), as their functional currencies. An entity’s functional currency is the currency of the primary economic environment in which it operates, normally that is the currency of the environment in which the entity primarily generates and expends cash. Management’s judgment is essential to determine the functional currency by assessing various indicators, such as cash flows, sales price and market, expenses, financing and inter-company transactions and arrangements.
 
Foreign currency transactions denominated in currencies other than the functional currency are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are re-measured at the applicable rates of exchange in effect at that date. Gains and losses resulting from foreign currency re-measurement are included in the statements of comprehensive loss.
 
The consolidated financial statements are presented in U.S. dollars. Assets and liabilities are translated into U.S. dollars at the current exchange rate in effect at the balance sheet date, and revenues and expenses are translated at the average of the exchange rates in effect during the reporting period. Stockholders’ equity accounts are translated using the historical exchange rates at the date the entry to stockholders’ equity was recorded, except for the change in retained earnings during the period, which is translated using the historical exchange rates used to translate each period’s income statement. Differences resulting from translating functional currencies to the reporting currency are recorded in accumulated other comprehensive income in the consolidated balance sheets.
 
Translation of amounts from RMB and HKD into U.S. dollars has been made at the following exchange rates:
 
Balance sheet items, except for equity accounts
 
 
 
 
 
 
 
 
December 31, 202
4
 
 
RMB
 
7.2993
to $1
 
 
 
HKD
 
7.7677
to $1
 
December 31, 202
3
 
 
RMB 
7.0827
to $1
 
 
 
HKD
 7.8158
 
to $1
 
 
 
 
 
 
 
 
 
 
Income statement and cash flows items
 
 
 
 
 
 
 
 
For the year ended December 31, 202
4
 
 
RMB
 
7.1957
to $1
 
  
 
  
 
  
HKD
 
7.803
to $1
 
For the year ended December
31, 202
3
 
 
RMB 7.0467 to $1
 
 
 
HKD
 7.8279
 
to
$1
 
 
 
F-11
 
 
Cash
 
Cash consist
s
of cash on hand and at banks and highly liquid investments, which are unrestricted from withdrawal or use, and which have original maturities of three months or less when purchased.
 
Accounts Receivable, Net
 
Accounts receivable is stated at the historical carrying amount net of allowance for doubtful accounts. The Company determines the allowance for doubtful accounts on an individual basis taking into consideration various factors including but not limited to historical collection experience and creditworthiness of the debtors as well as the age of the individual receivables balance.
 
Additionally, the Company would make specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use judgment in assessing its collectability.
 
A
llowance
for doubtful accounts
was nil and nil
as of December 31, 2024 and 2023.
 
Inventories
 
Inventories consist of raw materials, work-in-process, and finish
ed goods and are stated at lower of cost or net realizable value. Costs are computed under the weighted average method. Net realizable value is determined as estimated selling prices in the ordinary course of business, less reasonably predictable costs to sell. Valuation of inventories is based on currently available information about expected recoverable value. The estimate is dependent upon factors such as market trends, inventory ageing, and historical and forecasted customer demands. Inventory write-down
would be
recorded as cost of revenues.
No i
nventory write-down
was recognized in the year ended December 31,
 
2024 and
2023.
 
Long-Lived Assets
 
Long-lived assets consist primarily of equipment and intangible assets.
 
Equipment
 
Equipment is recorded at cost less accumulated depreciation and accumulated impairment. Depreciation is computed using the
accelerated depreciation
method over the estimated useful lives of the assets.
 
 
 
Estimated useful lives (years)
 
Office and computer equipment
 
 
3-5
 
Manufacturing equipment
 
 
10-20
 
 
Expenditure for maintenance and repairs is expensed as incurred.
 
The gain or loss on the disposal of equipment is the difference between the net sales proceeds and the lower of the carrying value or fair value less cost to sell the relevant assets
. The gain or loss
on the disposal
and impairment of equipment
are
recognized in general and administrative expenses in the consolidated statements of comprehensive loss.
 
 
 

Construction in progress
 
Construction in progress represents property, plant and equipment under construction and pending installation and is stated at cost less accumulated impairment losses, if any. Completed assets are transferred to their respective asset classes and depreciation begins when an asset is ready for its intended use.
 
Land Use Rights, Net
 
Land use rights are a form of intangible assets in the PRC. They are recorded at cost less accumulated amortization with no residual value. Amortization of land use rights are computed using the straight-line method over their estimated useful lives.
 
The estimated useful lives of the Company’s land use rights are as listed below:
 
 
 
Estimated useful lives (years)
 
Land use right
 
 
50
 
 
Goodwill
 
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination.
 
Goodwill is not depreciated or amortized but is tested for impairment on an annual basis as of December 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. In accordance with ASU 2017-04, Intangibles
Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment issued by the Financial Accounting Standards Board (
FASB
) guidance on testing of goodwill for impairment, the Group first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value, an impairment loss equal to the difference between the fair value of the reporting unit and its carrying amount will be recorded.

Application of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit.
 
The Company has only one reporting unit.
The Company recorded impairment losses on goodwill of nil and $2,507,455 during the years ended December 31, 2023 and 2024, respectively,
 
Impairment of Long-lived Assets
 
In accordance with ASC 360-10-35, the Company reviews the carrying values of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Based on the existence of one or more indicators of impairment, the Company measures any impairment of long-lived assets using the projected discounted cash flow method at the asset group level. The estimation of future cash flows requires significant management judgment based on the Company’s historical results and anticipated results and is
subject
to many factors. The discount rate that is commensurate with the risk inhere
nt in the Company’s business model is determined by its management. An impairment loss would be recorded if the Company determined that the carrying value of long-lived assets may not be recoverable. The impairment to be recognized is measured by the amount by which the carrying values of the assets exceed the fair value of the assets.
No i
mpairment
loss
has been recorded by the Company
in the years ended
December 31, 202
4
and 202
3
.
 
 
F-12
 
 
Net earnings per share of common stock
 
The Company has adopted ASC Topic 260, “Earnings per
Share
,” (“EPS”) which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying consolidation financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
 
 
 
202
4
 
 
202
3
 
 
 
 
 
 
 
 
Net
loss
 
$
(4,379,875
)
 
$
(7,132,573
)
 
 
 
 
 
 
 
 
 
Weighted average number of shares of common stock outstanding - basic
*
 
 
26,267,990
 
 
 
20,278,226
 
Add: potentially dilutive effect of shares issuable upon exercise of warrants
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
Weighted average number of shares of common stock outstanding - diluted
*
 
 
26,267,990
 
 
 
20,278,226
 
 
 
 
 
 
 
 
 
 
Net
loss
 per ordinary share
 
 
 
 
 
 
 
 
-Basic
 
$
(0.17
)
 
$
(0.35
)
-Diluted
 
$
(0.17
)
 
$
(0.35
)
 
* Retrospectively restated for the effect of 2-for-1 reverse stock split. (Note 1
8
)
 
On May 16, 2022, Northann entered into a securities purchase agreement with certain investors, pursuant to which the Company sold the investors convertible debentures in an aggregate principal amount of $1,000,000 that are convertible into shares of common stock of Northann with a 100% warrant coverage to purchase common stock of Northann and such shares underlying the warrants.
 
Segments
 
The Company evaluates a reporting unit by first identifying its operating segments, and then evaluates each operating segment to determine if it includes one or more components that constitute a business. If there are components within an operating segment that meets the definition of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable, when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically similar and, if so, the operating segments are aggregated. The Company has only one major reportable segment in the periods presented. The Company’s chief operation decision maker is the Company’s Chief Executive Officer.
 
Shipping and Handling Costs
 
Outbound shipping and handling costs are expenses as incurred and charged to the selling expense. Inbound shipping and freight are charged for raw material and components are accounted for as cost of revenues.
 
 
F-13
 
Fair Value of Financial Instruments
 
U.S. GAAP establishes a three-tier hierarchy to prioritize the inputs used in the valuation methodologies in measuring the fair value of financial instruments. This hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three-tier fair value hierarchy is:
 
Level 1 – observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
Level 2 – include other inputs that are directly or indirectly observable in the market place.
 
Level 3 – unobservable inputs which are supported by little or no market activity.
 
The carrying value of the Company’s financial instruments, including cash, accounts and other receivables, other current assets, accounts and other payables, and other short-term liabilities approximate their fair value due to their short maturities.
 
In accordance with ASC 825, for investments in financial instruments with a variable interest rate indexed to performance of underlying assets, the Company elected the fair value method at the date of initial recognition and carried these investments at fair value. Changes in the fair value are reflected in the accompanying consolidated statements of operations and comprehensive loss as other income (expense). To estimate fair value, the Company refers to the quoted rate of return provided by banks at the end of each period using the discounted cash flow method. The Company classifies the valuation techniques that use these inputs as Level 2 of fair value measurements.
 
As of December 31, 202
4
and 202
3
, the Company had no investments in financial instruments.
 
 
F-14
 
 
Leases
 
In February 2016, the FASB issued ASU 2016-12, Leases (ASC Topic 842), which amends the leases requirements in ASC Topic 840, Leases. Under the new lease accounting standard, a lessee will be required to recognize a right-of-use asset and lease liability for most leases on the balance sheet. The new standard also modifies the classification criteria and accounting for sales-type and direct financing leases, and enhances the disclosure requirements. Leases will continue to be classified as either finance or operating leases.
 
The Company adopted ASC Topic 842 using the modified retrospective transition method effective January 1, 2019. There was no cumulative effect of initially applying ASC Topic 842 that required an adjustment to the opening retained earnings on the adoption date nor revision of the balances in comparative periods. As a result of the adoption, the Company recognized a lease liability and right-of-use asset for each of the existing lease arrangement. The adoption of the new lease standard does not have a material impact on the consolidated income statements or the consolidated statements of cash flows.
 
The Company determines if an arrangement is a lease at inception. The lease payments under the lease arrangements are fixed. Non-lease components include payments for building management, utilities and property tax. It separates the non-lease components from the lease components to which they relate.
 
Lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the leases is not readily determinable. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The lease terms include periods under options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company generally uses the base, non-cance
l
able, lease term when determining the lease assets and liabilities.
 
Share-based compensation
 
The Company measures the cost of employee and non-employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award and recognizes the cost over the period the employee and non-employee is required to provide service in exchange for the award, which generally is the vesting period. The Company elects to recognize the effect of forfeitures in compensation costs when they occur. To the extent the required vesting conditions are not met resulting in the forfeiture of the share-based awards, previously recognized compensation expense relating to those awards is reversed.
 
Recent accounting prono
unce
ments

Recently adopted accounting pronouncements
 
In November 2023, the FASB issued ASU 2023-07.  The amendments improve reportable segment disclosure requirements. Main provisions include: (1) significant segment expenses—public entities are required to disclose significant segment expens
es by report
able segment if they are regularly provided to the CODM and included in each reported measure of segment profit or loss; (2) other segment items—public entities are required to disclose other segment items by reportable segment. Such a disclosure would constitute the difference between reported segment revenues less the significant segment expenses (disclosed) less reported segment profit or loss; (3) multiple measures of a segment’s profit or loss—public entities may disclose more than one measure of segment profit or loss used by the CODM, provided that at least one of the reported measures includes the segment profit or loss measure that is most consistent with GAAP measurement principles; (4) CODM-related disclosures—disclosure of the CODM’s title and position is required on an annual basis, as well as an explanation of how the CODM uses the reported measure(s) and other disclosures; (5) entities with a single reportable segment—public entities must apply all of the ASU’s disclosure requirements, as well as all existing segment disclosure and reconciliation requirements in ASC Topic 280, 
Segment Reporting
; (6) recasting of prior-period segment information to conform to current-period segment information—recasting is required if segment information regularly provided to the CODM is changed in a manner that causes the identification of significant segment expenses to change. The amendments in ASU 2023-07  are effective for all public entities for fiscal years beginning after December 15, 2023. Early adoption is permitted. A public entity should apply the amendments in this update retrospectively to all prior periods presented in the financial statements. The Company adopted this update beginning January 1, 2024.
Recently issued accounting pronouncements not yet adopted
 
In December 2023, the FASB issued ASU 2023-09, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. The ASU amends ASC 740-10-50-12 to require public business entities (“PBEs”) to disclose a reconciliation between the amount of reported income tax expense (or benefit) from continuing operations and the amount computed by multiplying the income (or loss) from continuing operations before income taxes by the applicable statutory federal (national) income tax rate of the jurisdiction (country) of domicile. If PBE is not domiciled in the United States, the federal (national) income tax rate in such entity’s jurisdiction (country) of domicile shall normally be used in the rate reconciliation. The amendments prohibit the use of different income tax rates for subsidiaries or segments. Further, PBEs that use an income tax rate in the rate reconciliation that is other than the U.S. income tax rate must disclose the rate used and the basis for using it. The ASU also adds ASC 740-10-50-12A,  which requires entities to annually disaggregate the income tax rate reconciliation between the following eight categories by both percentages and reporting currency amounts: (1) State and local income tax, net of federal (national) income tax effect; (2) Foreign tax effects; (3) Effect of changes in tax laws or rates enacted in the current period; (4) Effect of cross-border tax laws; (5) Tax credits; (6) Changes in valuation allowances; (7) Nontaxable or nondeductible items; (8) Changes in unrecognized tax benefits. PBEs must apply the ASU’s guidance to annual periods beginning after December 15, 2024 (2025 for calendar-year-end  PBEs). Early adoption is permitted. Entities may apply the amendments prospectively or may elect retrospective application. The Company is currently evaluating the impact from the adoption of this ASU on its consolidated financial statements.
 
In November 2024, the FASB issued ASU 2024-03 “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)”. The amendments in this update intend to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, selling, general and administrative expenses, and research and development). ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of this ASU on its consolidated financial statements.

 
 
F-15

 
3.
BUSINESS COMBINATION
 
In October 2024, in order to expand its sales, the Company acquired 100% equity interests of Cedar Modern Limited (“Cedar”) for consideration of 4,484,400 ordinary shares of the Company. Cedar is a trading company incorporated in Hong Kong.
 
The fair value of assets acquired, liabilities assumed and goodwill resulted for this acquisition are as follows:
 
 
 
 
Amount
 
 
 
 
US$
 
 
 
 
 
Amount due from related party
 
 
190,359
 
Total identifiable assets acquired
 
 
190,359
 
 
 
 
 
Total liabilities assumed
 
 
-
 
 
 
 
 
Net identifiable assets acquired
 
 
190,359
 
 
 
 
 
Number of Class A ordinary shares issued as consideration
 
 
4,484,400
 
Quoted price of Class A ordinary shares on acquisition date
 
 
0.168
 
Total purchase consideration
 
 
753,379
 
Goodwill
 
 
563,020
 
 
In November 2024, in order to expand its sales, the Company acquired 100% equity interests of Raleigh Industries Limited (“Raleigh”) for consideration of 4,500,000 ordinary shares of the Company. Raleigh is a trading company incorporated in Hong Kong.
 
The fair value of assets acquired, liabilities assumed and goodwill resulted for this acquisition are as follows:
 
 
 
 
Amount
 
 
 
 
US$
 
 
 
 
 
Amount due from related party
 
 
34,402
 
Total identifiable assets acquired
 
 
34,402
 
 
 
 
 
Total liabilities assumed
 
 
-
 
 
 
 
 
Net identifiable assets acquired
 
 
34,402
 
 
 
 
 
Number of Class A ordinary shares issued as consideration
 
 
4,500,000
 
Quoted price of Class A ordinary shares on acquisition date
 
 
0.395
 
Total purchase consideration
 
 
1,777,500
 
Goodwill
 
 
1,743,098
 
 
Goodwill is recognized as a result of expected synergies from combining operations of Cedar and Raleigh and the Company as well as other intangible assets that do not qualify for
separate
recognition. Goodwill is not amortized and is not deductible for tax purposes.
 
Pro forma results reflecting these two transactions were not presented because both acquirees were not significant to the Company’s consolidated financial results. Since the acquisition date, both Cedar and Raleigh contributed no revenues and no net income or loss to the Company.


F-16

 
 
4
.
RESTRICTED CASH
 
Restricted cash consist of the following: 
 
 
 
December 31,
202
4
 
 
 
 
December 31,
202
3
 
 
Deposit for Bank acceptance bill
 
$
-
 
 
$
3,771
 
 
 
 
 
 
 
 
 
 
Total
 
$
-
 
 
$
3,771
 
 
5
.
ACCOUNTS RECEIVABLE, NET
 
Accounts receivable consist of the following:
 
 
 
December 31,
202
4
 
 
 
 
December 31,
202
3
 
 
Gross accounts receivable
 
$
3,106,561
 
 
$
2,615,458
 
Total

 
$
3,106,561
 
 
$
2,615,458
 
 
There was no allowance for doubtful accounts recorded as of December 31,
202
4
,
and
202
3
.
 
 
 
F-17
 
 
6
.
OTHER RECEIVABLES
 
Other receivables consist of the following:
 
 
 
December 31,
202
4
 
 
 
 
December 31,
202
3
 
 
 
 
 
 
 
 
 
 
Deposit
and other receivables
 
 
74,984
 
 
 
127,313
 
Total
 
$
74,984
 
 
$
127,313
 
 
7
.
INVENTORY, NET
 
Inventories, net, consist of the following:
 
 
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
Raw materials and components
 
$
1,517,697
 
 
$
1,654,771
 
Finished goods
 
 
477,913
 
 
 
990,717
 
Inventories, net
 
$
1,995,611
 
 
$
2,645,488
 
 
A
loan
borrowed by the Company
from Bank of America is secured by the inventory
.

8
.
EQUIPMENT, NET
 
Equipment, net
consists
of the following:
 
 
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
 
 
 
 
 
 
 
 
Manufacturing equipment
 

8,315,845
 
 

8,790,918
 
Office equipment
 
 
314,748
 
 
 
319,624
 
L
ess: Accumulated depreciation
 
 
4,736,159
 
 
 
4,386,437
 
Total
 
$
3,894,434
 
 
$
4,724,105
 
 
Depreciation expenses charged to the consolidated statements of operations for the years ended
December
31,
2024 and 2023
were $ $625,434  and $657,556, respectively.

 
9
.
INTANG
IBLE ASSETS
, NET
 
 
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
 
 
 
 
 
 
 
 
Land use right
 
$
1,087,291
 
 
$
1,143,382
 
Software
 
 
23,154
 
 
 
-

 
less: Accumulated amortization
 
 
132,459
 
 
 
112,400
 
 
 
$
977,986
 
 
$
1,030,982
 
 
The Company has pledged its land use rights at No. 199, Newtag, Wujin District, Changzhou, Jiangsu Province, China, 213000 to Industrial and Commercial Bank of China Limited as a collateral for securing its loans. 

The expiry date of the land use right is in 2067.
 
Amortization expenses charged were $
22,611
and $
20,059
for the years ended December 31, 2023
and 202
4
, respectively. The
Company
expects to record amortization expenses of $
23,393
, $
23,393
, $
23,393
, $
23,393
, and $
23,393
for the years ending December 31, 202
5
, 202
6
, 202
7
, 202
8
, and 202
9
and years after, respectively
 
 
F-18
 
 
10
.
BANK BORROWINGS
 
Current
 
Short-term loans as of December 31, 202
4
and 202
3
represents bank borrowings of $
$
4,699,081
and $
5,689,721
, respectively obtained from financial institutions in the PRC. The short-term bank borrowings were secured by land use right. The weighted average interest rate for the short-term loans for the years ended December 31, 202
4
and 202
3
was approximately
4.30% and 4.48%, respectively.
 
Bank
 
Loan period
 
 
Interest
rate
 
 
Balance at
December 31,
2024
 
 
Balance at
December 31,
2023
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial and Commercial Bank of China
 
 
July 13, 2023-July 10, 2024
 
 
 
4.35
%
 
$
 
 
$
1,411,891
 
Industrial and Commercial Bank of China
 
 
June 4, 2024-June 12, 2025
 
 
 
4.35
%
 
 
1,369,994
 
 
 
-
 
Industrial and Commercial Bank of China
 
 
July 27, 2023-July 18, 2024
 
 
 
4.35
%
 
 
-
 
 
 
1,411,891
 
Industrial and Commercial Bank of China
 
 
June 4, 2024-June 1
0
, 2025
 
 
 
4.35
%
 
 
1,369,994
 
 
 
-

Bank of Communications
 
 
January 10, 2023-January 10, 2024
 
 
 
4.35
%
 
 
-
 
 
 
488,514
 
Bank of Communications
 
 
January 12, 2023-January 12, 2024
 
 
 
4.35
%
 
 
-
 
 
 
249,481
 
BANK OF AMERICA - Line of Credit
 
 
April 28, 2022 - April 30, 2024
 
 
 
Prime rate +0.1%
 
 
-

 
 
 
857,242
 
Jiangnan Rural Commercial Bank
 
 
May 26, 2020-February 27, 2024
 
 
 
4.79
%
 
 
-
 
 
 
381,211
 
Jiangnan Rural Commercial Bank
 
 
May 26, 2020-February 27, 2024
 
 
 
4.79
%
 
 
-

 
 
889,491
 
Jiangnan Rural Commercial Bank
 
 
February 28, 2024-February 27, 2025
 
 
 
4.79
%
 
 
1,232,994
 
 
 
-

 
Agricultural Bank of China, Changzhou Zhonglou Sub-branch
 
 
July 26, 2024-July 25, 2025
 
 
 
3.25

%
 
 
726,099
 
 
 
-
 
Total
 
 
 
 
 
 
 
$
4,699,081
 
 
$
5,689,721
 
 
 
The loan from Bank of America is secured by the Company’s inventory.
 
Non-current
 
Bank
 
Loan period
 
 
Interest
rate
 
 
 
 
 
 
Balance at
December 31,
202
4
 
 
 
 
 
 
Balance at
December 31,
202
3
 
 
 
EIDL Loan
 
 
From June 26, 2020 to June 25, 2050
 
 
 
3.75
%
 
 
136,947
 
 
 
124,905
 
Total
 
 
 
 
 
 
 
 
 
 
$
136,947
 
 
$
124,905
 
 
 
F-19
 
 
1
1
.
BALANCES WITH RELATED PARTY
 
1)
Related party transactions
 
For the year
s
ended December 31, 202
3
and 202
4
, the Company’s related party provided working capital
to
support
the Company’s operations when needed. The borrowings were unsecured, due on demand, and interest free. The following table summarizes borrowing transactions with the Company’s related party:
 
2)
Related party balances
 
Accounts
 
Name of Related Party
 
 
Note
 
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
 
Amount due to related party
 
 
Lin Li, Chief Executive Officer and Chairman of the Board
 
 
 
 
 
 
$
1,416,432
 
 
$
302,943
 
 
All the above balances are due on demand, interest-free and unsecured. The Company used the funds for its
operations
.
 
1
2
.
EQUITY
 
Preferred Stock
 
The Company is authorized to issue 500,000,000 shares of capital stock, consisting of 400,000,000 shares of common stock, par value US$0.001 per share, and 100,000,000 shares of preferred stock, par value US$0.001 per share. 20,000,000 shares were designated to be series A preferred stock (the “Series A Preferred Stock”) out of the 100,000,000 shares of blank check preferred stock. Each share of common stock is entitled to one vote and each share of Series A Preferred Stock is entitled to ten votes on any matter on which action of the stockholders of the corporation is sought. The Series A Preferred Stock will vote together with the common stock. Common stock and Series A Preferred Stock are not convertible into each other. Holders of Series A Preferred Stock are not entitled to receive dividends. The Series A Preferred Stock does not have liquidation preference over the Company’s Common Stock, and therefore ranks pari passu with the Common Stock in the event of liquidation.
 
Common Stock
 
  
The Company is authorized to issue 400,000,000 shares of common stock with par value of US$0.001 per share.  Each share of common stock entitles the holder to one vote. For the sake of comparability, the share structure as of the date of this report has been carried back in the Company’s statement of stockholders’ equity as if they had been issued and outstanding from the beginning of the first period presented.
  
 
1
3
.
INCOME TAXES
 
United States of America
 
The Coronavirus Aid, Relief and Economy Security (CARES) Act (“the CARES Act, H.R. 748”) was signed into law on March 27, 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a material impact on its financial statements as of December 31, 202
4
and 202
3
due to the recent enactment.
 
 
F-20
 
 
Hong Kong
 
Two-tier Profits Tax Rates
 
The two-tier profits tax rates system was introduced under the Inland Revenue (Amendment)(No.3) Ordinance 2018 (the “Ordinance”) of Hong Kong became effective for the assessment year 2018/2019. Under the two-tier profit tax rates regime, the profits tax rate for the first HKD 2 million (approximately $257,868) of assessable profits of a corporation will be subject to the lowered tax rate, 8.25% while the remaining assessable profits will be subject to the legacy tax rate, 16.5%. The Ordinance only allows one entity within a group of “connected entities” is eligible for the two-tier tax rate benefit. An entity is a connected entity of another entity if (1) one of them has control over the other; (2) both of them are under the control (more than 50% of the issued share capital) of the same entity; (3) in the case of the first entity being a natural person carrying on a sole proprietorship business-the other entity is the same person carrying on another sole proprietorship business. Since Benchwick is wholly owned and under the control of Northann, it is a connected entity. Under the Ordinance, it is an entity’s election to nominate the entity that will be subject to the two-tier profits tax rates on its profits tax return. The election is irrevocable. The Company elected Benchwick to be subject to the two-tier profits tax rates.
 
The provision for current income and deferred taxes of Benchwick has been calculated by applying the new tax rate of 8.25%.
 
PRC
 
In accordance with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All the PRC subsidiaries that are not entitled to any tax holiday were subject to income tax at a rate of 25% for the year ended December 31,
2024 and 2023
. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred. Carry back of losses is not permitted. If not utilized, the PRC net operating loss will expire in 2026.
 
The income tax expense was $
1,733
and $
14,361
for the years ended December 31, 202
4
and 202
3
, respectively, related primarily to the Company’s subsidiaries located outside of the U.S. The income before provision for income taxes for the years ended December 31, 202
4
and 202
3
was as follows:
 
The income tax provision consists of the following components:
 
 
 
For the year ended
December 31,
202
4
 
 
 
 
 
 
For the year ended
December 31,
202
3
 
 
 
Current:
 
 
 
 
 
 
 
 
Federal
 
$
-
 
 
$
-
 
State
 
 
(108
)
 
 
12,851
 
Foreign
 
 
1,841
 
 
 
1,509
 
Total current
 
$
1,733
 
 
$
14,361
 
 
 
 
 
 
 
 
 
 
Deferred:
 
 
 
 
 
 
 
 
Federal
 
$
-
 
 
$
-
 
State
 
 
-
 
 
 
-
 
Foreign
 
 
-
 
 
 
-
 
Total deferred
 
$
-
 
 
$
-
 
Total income tax expense
 
$
1,733
 
 
$
14,361
 
 
 
F-21
 
 
A reconciliation between the Company’s actual provision for income taxes and the provision at the United States statutory rate is as follow:
 
 
 
For the year ended
December 31,
202
4
 
 
 
 
 
 
For the year ended
December 31,
202
3
 
 
 
Loss
before income tax expense
 
 
 
$
(4,378,142
)
 
$
(7,118,212
)
Computed tax benefit with statutory tax rate
 
 
29.84
%
 
 
29.84
%
Income tax expense computed at statutory income tax rate
 
 
(1,306,437
)
 
 
(2,124,074
)
Impact of different tax rates in other jurisdictions
 
 
1,115,557
 
 
 
1,935,475
 
Tax effect of non-deductible expenses
 
 
192,615
 
 
 
 
 
202,961
 
Total income tax expense
 
$
1,733
 
 
 
$
14,361
 
 
The effective tax rate were (0.04%) and
(
0.2%
)
for the years ended December 31, 202
4
and 202
3
, respectively.
 
Uncertain tax positions
 
The Company did not have any uncertain tax positions during the years ended December 31, 202
4
and 202
3
.
 
The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by the respective jurisdictions, where applicable. The statute of limitations for the tax returns varies by jurisdictions.
 
 
F-22
 
The amounts of uncertain tax liabilities listed above are based on the recognition and measurement criteria of ASC Topic 740, and the balance is presented as current liability in the consolidated financial statements as of December 31, 202
4
. The Company anticipated that the settlements with the taxing authority are remitted within one year.
 
Our policy is to include interest and penalty charges related to
uncertain
tax liabilities as necessary in the provision for income taxes. The Company has a liability for accrued interest of $nil as of December 31, 202
4
and 202
3
, respectively.
 
The statute of limitations for the Internal Revenue Services to assess the income tax returns on a taxpayer expires three years from the due date of the profits tax return or the date on which it was filed, whichever is later.
 
In accordance with the Hong Kong profits tax regulations, a tax assessment by the IRD may be initiated within six years after the relevant year of assessment, but extendable to 10 years in the case of potential willful underpayment or evasion.
 
In accordance with PRC Tax Administration Law on the Levying and Collection of Taxes, the PRC tax authorities generally have up to five years to assess underpaid tax plus penalties and interest for PRC entities’ tax filings. In the case of tax evasion, which is not clearly defined in the law, there is no limitation on the tax years open for investigation. Accordingly, the PRC entities remain subject to examination by the tax authorities based on the above.
 
1
4
.
CHINA CONTRIBUTION PLAN
 
The Company participates in a government-mandated multi-employer defined contribution plan pursuant to which certain retirement, medical and other welfare benefits are provided to employees. Chinese labor regulations require the Company to pay to the local labor bureau a monthly contribution at a stated contribution rate based on the monthly compensation of qualified employees. The relevant local labor bureau is responsible for meeting all retirement benefit obligations; the Company has no further commitments beyond their monthly contributions. For the years ended December 31, 202
4
and 202
3
, the Company contributed a total of
$
67,699
and $
69,131
, respectively, to these funds.
 
1
5
.
OPERATING LEASE
 
The Company has operating leases for its office facilities. The lease is located at 9820 Dino Drive, Suite 110, Elk Grove, California, 95624, which consist of approximately 3,653 square meters. The Company's leases have remaining terms of approximately 37 months for a lease term commencing on August 1, 2020 and ending on August 31, 2023.
The lease was renewed for additional 36 months
. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company does not separate non-lease components from the lease components to which they relate, and instead accounts for each separate lease and non-lease component associated with that lease component as a single lease component for all underlying asset classes.
 
The following table provides a summary of leases by balance sheet location as of December 31, 202
4
 
and 202
3
:
 
Assets/liabilities
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
 
Assets
 
 
 
 
 
 
 
 
Operating lease right-of-use assets
 
$
1,822,266
 
 
$
87,380
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
Operating lease liability - current
 
$
355,754
 
 
$
31,413
 
Operating lease liability - non-current
 
 
1,466,512
 
 
 
55,967
 
Total lease liabilities
 
$
1,822,266
 
 
$
87,380
 
 
 
F-23
 
 
The operating lease expenses for the year ended December 31, 202
4
 
and 202
3
were as follows:
 
Lease Cost
 
Classification
 
 
December 31,
202
4
 
 
 
 
December 31,
202
3
 
 
Operating lease expense


General and administrative
 
expenses


$
438,854
 
 
$
30,274
 
 
Maturities of operating lease liabilities as of December 31, 202
4
 were as follows:
 
Maturity of Lease Liabilities
 
Operating
Leases
 
 
 
12 months ending December 31,
 
 
 
  
202
5
 
$
438,854
 
202
6
 
 
439,278
 
202
7
 
$
428,376
 
2028
 
 
441,227
 
202
9
 
 
299,976
 
Total lease payments
 
$
2,047,712
 
Less: interest
 
 
(225,445
)
Present value of lease payments
 
$
1,822,266
 
 
Lease liabilities include lease and non-lease component such as management fee.
 
Future minimum lease payments, which do not include the non-lease components, as of December 31, 202
4
 were as follows:
 
12 months ending December 31,
 
 
 
 
202
4
 
$
35,069
 
2025
 
 
35,069
 
2026
 
 
23,379
 
Total lease payments
 
$
93,517
 
 
Lease Term and Discount Rate
 
December 31,
202
4
 
 
 
 
 
 
December 31,
202
3
 
 
 
Weighted-average remaining lease term (years)
 
 
 
 
 
 
 
 
 
 
Operating leases
 
 
4.57
 
 
 
 
 
2.92
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average discount rate (%)
 
 
 
 
 
 
 
 
 
 
Operating leases
 
 
5
%
 
 
5
%
 
1
6
.
CONCENTRATIONS AND CREDIT RISK
 
(a)
Concentrations
 
During the fiscal year ended December 31, 202
4
, two customers accounted for nearly
72
% of the Company’s revenues. During the fiscal year ended December 31, 202
3
, two customers accounted for nearly
91
% of the Company’s revenues.  No other customer accounts for more than 6% of the Company’s revenue in the years ended December 31,
2024 and 2023
.
 
As of December 31, 202
4
, five customers accounted for
 
94
% of the Company’s accounts receivable. As of December 31, 202
3
, five customers accounted for 72% of the Company’s accounts receivable. No other customer accounts for more than
3
% of the Company’s accounts receivable for the years ended December 31, 202
4
and 202
3
.
 
During the fiscal year ended December 31, 202
4
,
five
suppliers accounted for a total of
48%
of the Company’s cost of revenues. During the fiscal year ended December 31, 202
3
, three  suppliers accounted for a total of
32
%of the Company’s cost of revenues. No other supplier accounts for over 4% of the Company’s cost of revenues.
 
 
F-24
 
 
As of December 31, 202
4
, one supplier accounted for over
10
% of the Company’s accounts payable. As of December 31, 202
3
, one supplier accounted for
10
% of the Company’s accounts payable.
 
(b)
Credit risk
 
Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash. As of December 31, 202
4
and 202
3
, substantially all of the Company’s cash were held by major financial institutions located in the PRC, Hong Kong, and the United States, which management believes are of high credit quality. Deposits in the United States up to $250,000 are insured by the Federal Depository Insurance Corporation.
 
For the credit risk related to trade accounts receivable, the Company performs ongoing credit evaluations of its customers and, if necessary, maintains reserves for potential credit losses. Historically, such losses have been within management’s expectations.
 
1
7
.
COMMITMENTS AND CONTINGENCIES
 
Capital
commitments
 
On July 26, 2021, the Company has contracted Changzhou Wanyuan Construction Engineering Co. to build a second phase of its factory. The amount required in the contract is $
5.05
million. Construction is expected to
complete in June 2025.
As of December 31, 202
4
, the Group had a commitment for the
construction
amounted to $
4.3
million.
 
Legal proceedings
 
From time to time, the
Company
may become involved in litigation, claims, and proceedings. The
Company
evaluates the status of each legal matter and assesses the potential financial exposure. If the potential loss from any legal proceedings or litigation is considered probable and the amount can be reasonably estimated, the
Company
accrues a liability for the estimated loss. Significant judgment is required to determine the probability of a loss and whether the amount of the loss is reasonably estimated. As of December 31, 202
3
and 202
4
, based on the information currently available, the
Company
believes that the loss contingencies that may arise as a result of currently pending legal proceedings are not reasonably possible to have a material adverse effect on the
Company’
s business, results of operations, financial condition, and cash flows
.
 
1
8
.
STOCK SPLIT
 
Effective on July 6, 2023, the Company implemented a 
2-for-1
 reverse stock split of the issued and outstanding shares. Under the reverse split, every two shares of outstanding shares issued and outstanding were automatically converted into one share of ordinary share, with a par value of US$ 0.001 each. Except as otherwise indicated, all information in the consolidated financial statements concerning share and per share data gives retroactive effect to the 
2-for-1
 reverse stock split. The total number of outstanding common shares immediately before the reverse split was 40,000,000 and immediately after the reverse split was 20,000,000. The total number of outstanding preferred shares immediately before the reverse split was 10,000,000  and immediately after the reverse split was 5,000,000.
 
1
9
.
SECURED BORROWING ARRANGEMENT
 
In July 2023, the Company signed a secured borrowing agreement with a financial institution in the United States, in which the Company borrowed $1,000,000 secured by its accounts receivable amounted $1,491,000
 
It is scheduled under the agreement that the Company pays $49,700 per week for thirty weeks to the financial institution to repay the loan.
 
 
F-25
 

On January 21, 2025, 3D PRINTING entered into an EB-5 loan agreement (the “Loan Agreement”) with 3DFLOR Chairman and controlling shareholder, Lin Li (“3DFLOR”), pursuant to which 3DFLOR agreed to provide 3D PRINTING a loan, with an initial maximum principal amount of
$24,000,000 at an interest rate of 1.00% per year.

 
 

20.
SUBSEQUENT EVENT

On January 21, 2025, 3D PRINTING entered into an EB-5 loan agreement (the “Loan Agreement”) with 3DFLOR OPPORTUNITY, LP, a Delaware limited partnership and a related party controlled by the Company’s CEO, Chairman and controlling shareholder, Lin Li (“3DFLOR”), pursuant to which 3DFLOR agreed to provide 3D PRINTING a loan, with an initial maximum principal amount of $24,000,000 at an interest rate of 1.00% per year.
 
In connection with the Loan Agreement, 3D PRINTING issued a promissory note to 3DFLOR in an amount of $24,000,000, dated January 27, 2025 (the “Promissory Note”). The Promissory Note bears the interest of one percent (1%) per year and the interest shall be non-compounding and calculated on the basis of a 366-day year, payable on the basis of the actual number of days elapsed. Pursuant to the Loan Agreement, the principal is due and is repayable in full on the third (3rd) anniversary of the closing date of the Loan Agreement.
 
In connection with the Loan Agreement, on January 27, 2025, Benchwick LLC
entered into a membership interest pledge agreement with 3DFLOR and 3D PRINTING, in favor of 3DFLOR (the “Pledge Agreement”), to pledge to 3DFLOR (i) all 49 million Class A Units of 3D PRINTING it owns (the “Pledged Units”) and (ii) all proceeds and products of the Pledged Units (collectively with the Pledged Units, “Collateral”), as security for the performance of 3D PRINTING’s obligations under the Loan Agreement.
 
On February 27, 2025, 3D PRINTING filed a UCC-1 Financing Statement securing 3DFLOR’s security interests in the Collateral with Delaware. The Company’s audit committee approved and ratified the above mentioned transactions.


The
C
ompany
initiated a lawsuit against Newivy Flooring in the Sacramento court during the second quarter of 2025, with a claim amount of $56,454.49.


F-26


2
1
.
UNRESTRICTED NET ASSETS
 
The following presents condensed financial information of Northann Corp:
 
Condensed Financial Information on Financial Position 
 
 
As of December 31,
 
 
 
202
4
 
 
202
3
 
Cash
 
 
-
 
 
 
370
 
Amounts due from subsidiaries
 
 
4,422,688
 
 
 
5,504,920
 
Total current assets
 
 
4,422,688
 
 
 
5,505,290
 
All other non-current assets
 
 
-
 
 
 
-
 
Interests in a subsidiary
 
 
9,452,997
 
 
 
9,948,890
 
Total Assets
 
 
13,875,685
 
 
 
15,454,180
 
 
 
 
 
 
 
 
 
 
Liabilities and Stockholders’ Deficit
 
 
 
 
 
 
 
 
All other current liabilities
 
 
358,626
 
 
 
599,664
 
Amounts due to subsidiaries
 
 
10,881,994
 
 
 
10,660,508
 
Total current liabilities
 
 
11,240,620
 
 
 
11,260,172
 
Non-current liabilities
 
 
35,892
 
 
 
1,950,000
 
Total Liabilities
 
 
11,240,620
 
 
 
13,210,172
 
 
 
 
 
 
 
 
 
 
Stockholders’ Equity (Deficit)
 
 
 
 
 
 
 
 
Preferred stock,100,000,000 shares authorized – Series A, $0.001 par value, 20,000,000 shares designated, 5,000,000 shares issued and outstanding as of December 31,
2024 and 2023
*
 
 
5,000
 
 
 
5,000
 
Common stock, $0.001 par value, 400,000,000 shares authorized, 55,464,000 and 
20,000,000
shares issued and outstanding as of December 31,
2024 and 2023
, respectively*
 
 
55,464
 
 
 
21,380
 
Subscription receivable
 
 
(1,375,000
)
 
 
(25,000
)
Additional Paid-in Capital
 
 
15,487,165
 
 
 
6,671,016
 
Accrued compensation expense
 
 
(2,927,250
)
 
 
-
 
(Accumulated deficit) re
tained earnings
 
 
(9,693,818
)
 
 
(3,652,547
)
Accumulated other comprehensive loss
 
 
1,047,612
 
 
(775,841
)
Total Stockholders’ Equity
 
 
2,599,173
 
 
2,244,008
 
Total Liabilities and Stockholders’ Deficit
 
 
13,875,685
 
 
 
15,454,180
 
 
*
Retrospectively restated for the effect of 2-for-1 reverse stock split. (Note 1
8
)
 
 
F-27
 
 
Condensed Financial Information on Results of Operations 
 
 
 
For the years ended
December 31,
 
 
 
 
202
4
 
 
202
3
 
Revenue
 
 
250,000
 
 
 
43,251
 
Cost or revenues
 
 
-
 
 
 
-
 
Operating expenses
 
 
2,668,613
 
 
 
3,381,482
 
Income taxes
 
 
1,733
 
 
 
12,919
 
L
oss – Parent only
 
 
(2,420,347
)
 
 
(3,351,150
)
I
ncome
 (loss)
– Subsidiaries with unrestricted net assets
 
 
1,175,106

 
 
(2,117,498
)
Loss – Subsidiaries with restricted net assets
 
 
(3,134,633
)
 
 
(2,529
)
Net
loss
 – Consolidated
 
 
(4,379,875
)
 
 
(5,471,177
)
 
Condensed Financial Information on Cash Flows
 
 
 
For the years ended
December 31,
 
 
 
 
202
4
 
 
202
3
 
Cash used in operating activities
 
 
(2,420,347
)
 
 
(5,965,604
)
Cash used in investing activities
 
 
-
 
 
 
 
 
 
-

Cash provided by financing activities
 
 
2,419,977
 
 
 
5,965,750
 
Net cash flows
 
 
(370
)
 
 
 
 
146
 
Beginning cash balance
 
 
370
 
 
 
224
 
Ending cash balance
 
 
-
 
 
 
 
 
 
370
 
 
 
(i)
Basis of presentation
 
The condensed financial information reflects the accounts of the Company. The condensed financial information should be read in connection with the consolidated financial statements and notes thereto. The condensed financial information is presented as if the incorporation of the Company were in effect since January 1, 2020,
 
 
(ii)
Restricted Net Assets
 
Schedule I of Rule 5-04 of Regulation S-X requires the condensed financial information of registrant shall be filed when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. For purposes of the above test, restricted net assets of consolidated subsidiaries shall mean that amount of the registrant’s proportionate share of net assets of consolidated subsidiaries (after intercompany eliminations) which as of the end of the most recent fiscal year may not be transferred to the parent company by subsidiaries in the form of loans, advances or cash dividends without the consent of a third party (i.e., lender, regulatory agency, foreign government, etc.). The Company’s only assets are its equity interests in its subsidiaries. Unrestricted net assets are held in the Company’s subsidiaries located in the US and Hong Kong. The Company does maintain substantial assets and operating subsidiaries in China; therefore, the ability for operating subsidiaries to pay dividends or transfer assets to the Company may be restricted due to the foreign exchange control policies and availability of cash balances of the Chinese operating subsidiaries.
 
As of December 31, 202
4
and 202
3
, there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or redemption requirements of redeemable stocks or guarantees of the Company, except for those which have been separately disclosed in the Consolidated Financial Statements, if any.
 
 
F-28

FAQ

What insider transaction did Jamie L. Reynoso report for CLOV?

217,523 RSUs vested and 85,596 shares were withheld for taxes on 30 June 2025.

How many Clover Health shares does Reynoso own after the Form 4 filing?

She now directly owns 3,328,328 Class A shares.

Were any open-market purchases or sales involved?

No. The acquisition came from RSU vesting; the share sale was automatic tax withholding, not discretionary trading.

At what price were shares sold to cover taxes?

Shares were sold at $2.79 per share.

Does the filing indicate use of a Rule 10b5-1 plan?

No Rule 10b5-1 box is marked; the sale was automatic for tax withholding.
Northann Corp

NYSE:NCL

NCL Rankings

NCL Latest News

NCL Stock Data

9.98M
53.72M
75.27%
0.54%
0.48%
Furnishings, Fixtures & Appliances
Plastics Products, Nec
Link
United States
FORT LAWN